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ABSTRACT
Clones of L1210 cells have been isolated in the presence of toxic concentration of 5 
mM 3-acetamidobenzamide (3-AAB), an inhibitor of ADPR-transferase. It was 
initially suggested that resistance to the drug could be due to a defect in the process 
of ADP-ribosylation, especially cells deficient in ADPR transferase. Results show 
however that m utant cell lines have ADPR transferase activity and its activity is 
completly inhibited by 3-AAB. Furthermore, 3-AAB also enhances cytotoxicity of 
DMS in mutant cell lines. Other characterizations of m utant cell lines indicate that 
they have prolongelgeneration times in the presence and absence of 5 mM 3-AAB. 
They are sensitive to 3-aminobenzamide and 3- nitrobenzamide which are ADPR 
transferase inhibitors. M utant 3 however has shown to be more resistant to 3- 
aminobenzamide than wild-type cells. The characterization of ADPR transferase in 
mutant 3 has shown that the Km and Vmax values for NAD are 3 times higher than 
those obtained in wild-type cells and it has a higher DNA content (2 fold) compared 
with wild-type cells. M utant 3 may be of value in other aspects not related to 
ADP-ribosylation. The usefulness of m utant cells can be verified when further 
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ADP-ribosylation is a protein modification process which occurs widely in nature 
(see 1.1.2). NAD is used as a substrate and as part of a molecular mechanism for 
modulating the activity of a wide variety of cellular proteins (see 1.1.1). The 
reactions are catalysed by enzymes called ADPR transferases.
It has been about 25 years since the discovery of poly (ADP- ribose), a nuclear 
modification, by Chambon et al.,( 1963). Protein ADP-ribosylation has also gained an 
increasing amount of attention which is attributable to its postulated role in the 
DNA repair process (see 1.1.9). Because of its proposed involvement in this and 
other major cellular events such as cell proliferation (see 1.1.6), differentiation (see 
1.1.8), DNA metabolism (see 1.1.7) and gene expression (see 1.1.7), the poly (ADP- 
ribose) field is. therefore, attracting many workers, especially from established 
mammalian DNA repair laboratories.
The introduction of this thesis w ill give a general review of nuclear ADP- 
ribosylation with particular emphasis on some of the reports emerging during the 
last few years (Part I) together w ith a review of mammalian cell mutation (Part II). 
The overall aim of this thesis is the development of. and investigation into ADPR 
transferase m utants in a mouse L1210 cell line.
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PARTI
1.1.1 METABOLISM OF NAD
The process of NAD synthesis (see figure 1) starts in the cytoplasm. NMN is 
synthesized by NMN pyrophosphorylase from nicotinamide and phosphoribosyl 
pyrophosphate. NMN diffuses into the nucleus for the next step, where NMN and 
ATP are coupled to form NAD by NAD pyrophosphorylase. This enzyme has been 
found to be located exclusively in the cell nucleus (Hogboom and Schneider, 1952).
NAD is broken down in the cell in a variety of ways but the main pathway of 
breakdown (90%) occurs via the ADPR transferase systems (Rechsteiner et al., 
1976). About 5% is used in the normal coenzyme function of NAD in intermediary 
metabolism within the cell (Hillyard et al., 1973). It has been shown that the half- 
life of NAD in human cell line D98/AH2 is about one hour (Reichsteiner et al., 
1976).
1.1.2 BIOSYNTHESIS AND BIOCHEMICAL CHARACTERIZATION OF POLY 
(ADP - RIBOSE)
Poly (ADP-ribose) is a unique biopolymer of nuclear origin, consisting of repeating 
units of ADP-ribose formed by the DNA bound enzyme ADPR transferase. This 
enzyme appears to be capable of catalyzing three separate related reactions (Ueda et 
al., 1980) (figure 2).
1) Initiation (ADP-ribose) transfer to acceptor protein
2) Branching (addition of ADP-ribose) units on to poly (ADP- ribose) chains
- 2 -
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_  _  Nm 4- (ADPR)n A nuclear protein-
bound to DNA
11 ADPR Poly ADPR glycohydrolase
FIGURE 1 NAD metabolism in nucleated cells.
Nm = Nicotinamide
Prpp *s Phosphoribosyl pyrophosphate
NMN = Nicotinamide mononucleotide
NAD = Nicotinamide adenine diphosphate
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FIGURE 2 Structure of poly (ADP - ribose).
3) Elongation (addition of ADP-ribose) units on pre- existing mono - or oligo - 
(ADP-ribose)
The linear and branching forms of poly (ADP-ribose) have the same alpha (1-2) 
ribose-ribose linkage (Miwa et al., 1981). An acceptor linked ADP-ribose unit was 
demonstrated to be elongated by terminal addition of new ADP-ribose units (Ueda 
et at., 1979).
The precise role and mechanism of automodification on the surface of the enzyme is 
still not fu lly  understood. Reports from two laboratories are contradictory to one 
another. Taniguchi (1987), using a pulse-chase experiment, first labelled ADPR 
transferase w ith [3H] NAD (pulse-labelled) in the presence of Mg2+ and then chased 
with [14C] NAD under the same conditions after complete washing of [3H] NAD. 
Poly (ADP-ribose) was then digested with snake venom phosphodiesterase and 
analyzed. The [3H]-labelled product was identified as iso-ADP-ribose and the only 
terminal AMP was detected as [14C]-labelled AMP (see figure 2). Results indicate 
that the initially attached ADP-ribose unit at the automodification site was 
successively elongated by the addition of a new ADP-ribose unit to the terminal 
AMP only. However, results from Ikejima et al. (1987) using pulse-chase 
experiment, first with radioactive NAD then followed by non radioactive NAD, 
have shown that the new ‘ADP-ribose’ residues are added at 1" terminus, adjacent to 
ADPR transferase, such that the first ADP-ribose unit links to the next at the 
catalytic site. This is then extended out to become the terminal ADP-ribose. The 
same group also found that poly (ADP-ribose) glycohydrolase digests poly (ADP- 
ribose) w ith an endonucleotic incision and then removes the ADP-ribose residues 
progressively in the 2'-»l" direction (ie toward ADPR transferase) (Ikejima and Gill, 
1988). They have suggested tha t the two mechanisms which move in the opposite
- 5  -
direction will allow a single poly (ADP-ribose) chain to be extended at one end and 
simultaneously degraded at the other end, thus controlling the quantity and 
distribution of polymer around the DNA break.
The number of chains and the chain lengths of poly (ADP-ribose) can be estimated 
by isolation and quantification of the products of snake venom phosphodiesterase 
digestion. This was the first enzyme found to hydrolyze poly (ADP-ribose) 
(Nishizuka et al.. 1968) producing 5’-AMP from the terminus and a unique 
molecule, 2-(5H-phosphoribosyl)-5’-AMP (PR-AMP) (see figure 3) from each 
internal residue. These two products can be separated by thin layer 
chromatography (Nishizuka et al., 1969) providing a quantitative estimate of the 
chain length. The product PR-AMP can be digested with alkaline phosphatase but it 
is resistant to digestion by snake venom phosphodiesterase. In contrast, ADP-ribose 
is digested by snake venom phosphodiesterase into ribose phosphate and 5 '-AMP 
(Ikejima et al.. 1980; Wielckens et al.. 1981).
The products, 5’-AMP, PR-AMP and ADP-ribose can be quantitatively determined 
by radioimmunoassay using antisera highly specific for the respective product. 
Bredehorst et al. (1978) used alkali treatm ent to cleave mono ADP-ribose residues to 
5’-AMP and ribose-5-phosphate and then used highly specific antibodies raised 
against 5 ’- AMP to quantify ADP-ribose by radioimmunoassay. Following the 
enzymatic degradation of the polymer, antibodies raised against 5’- AMP and PR- 
AMP were used to determine the polymeric ADP-ribose level. Adamietz and 
Bredehorst (1981) later used alkali in the presence of Mg2+ ions to degrade the 
ADP-ribose polymer directly to PR-AMP and 5'-AMP (instead of using degrading 
enzymes, which could give incomplete digestion) and suggested that such a cleavage 
method would allow determination of chain lengths in vivo. On the other hand,
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ribosyl adenosine can be quantitatively estimated by HPLC. This is usually 
performed after the conversion of the compound to a fluorescent analogue (Juarez- 
Salinas et al', 1979; Sim et al., 1980). The unique nucleotides ribosyl adenosine and 
diribosyl adenosine are released from linear and branched ADP - 
ribose polymers by digestion with snake venom phosphodiesterase and poly (ADP- 
ribose) glycohydrolase (Miwa and Sugimura, 1971; Sims et al., 1980; Juarez-Salinas 
et al., 1983). The fluorescent derivatives are then separated by HPLC and measured.
In animal tissues, poly (ADP-ribose) may be hydrolysed by two classes of enzymes. 
One is poly (ADP-ribose) glycohydrolase, an exoglycosylase, which cleaves the 
ribose-ribose bonds and also the branch region of poly (ADP-ribose) containing 
ribose-ribose-ribose to yield ADP-ribose. Poly (ADP-ribose) glycohydrolase has 
been purified from many tissues ie from calf thym us (Hatakeyama et al., 1986), 
human erythrocytes (Tanuma et al., 1986b) and from the nuclei of guinea pig liver 
(Tanuma et al., 1986a). The second degrading enzyme is a phosphodiesterase which 
splits the phosphate-phosphate bonds in the polymer producing phospho-ribosyl- 
AMP and 5’-AMP (Futai et al., 1968) (figure 3). Phosphodiesterase may be 
endonucleolytic or exonucleolytic (Miwa and Sugimura, 1982). The pH optimum 
for poly (ADP-ribose) glycohydrolase is pH 7.6 whereas the pH optimum for 
phosphodiesterase is about pH 10. Hence, poly (ADP-ribose) glycolhydrolase is the 
more physiologically im portant enzyme for degradation. Moreover, analysis of the 
degradation products of the polymer in vivo indicated that the glycohydrolase is 
mainly responsible for polymer degradation in various tissues (Miwa et al., 1975).
1.1.3 NUCLEAR ADPR TRANSFERASE
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Schematic representation of poly (ADPR) metabolism.
The sites of cleavage by ADP-ribosylation protein lyase(L), snake venom 
phosphodiesterase (S), and poly ADPR glycohydrolase (G) are indicated by arrows. 
(White, 1988).
ADP-ribose polymerization. It transfers ADP-ribose residues to various protein 
acceptors with the release of nicotinamide and hydrogen ions. This enzyme is 
present in the nuclei of both animals and plants. It is also found in lower organisms 
such as the dinoflagellate Crypthecodinium cohnii (Werner et al., 1984) and the slime 
mould Physarum polycephalum (Brightwell et al., 1975). However, this enzyme 
activity is reported to be absent in many differentiated cells eg mature granulocytes 
(Ikai et al., 1980a, b) epidermal cells (Ikai et al., 1981) and in intestinal epithelial 
cells (Porteous and Pearson, 1982). The enzyme activity is localized in the nucleus 
of eukaryotic cells and 80% to 90% of it was shown to be associated with chromatin 
(Ueda et al., 1968). Some cytoplasmic ADPR transferase has also been found in 
mitochondria of rat liver (Masmoudi and Mandel, 1987) and in ribosomes (Concha 
et al., 1985). The latter case, the enzyme was found to be associated with free 
messenger ribonucleoprotein particles and it is able to modify several proteins from 
these particles (Thomassin et al., 1985).
ADPR transferase requires Mg2+ and thiol reagents for maximal activity (Carter 
and Berger, 1981a). Furthermore it has an absolute requirement for DNA and it is 
greatly activated by DNA strand breaks (Hayaishi and Ueda, 1982). Using gel 
retardation and electron microscopy, it was shown that ADPR transferase forms 
loops with DNA and that in the absence of single or double stranded breaks it 
preferentially binds to superhelical DNA (Gradwohl et al., 1987). The activity of 
the enzyme, in vitro, could be inhibited through the process of itself being 
phosphorylated by protein kinase C (Tanaka et al., 1987).
An interesting property of ADPR transferase is that it is solely responsible for 
catalysing both the initiating event, when the first ADP-ribose residue is attached to 
the acceptor sites, and the further covalent attachment to this or other ADP-ribose
moieties (Kawaichi et al., 1980) Jones and Skidmore (1984) have proposed that the 
enzyme may contain more than one catalytic site, such that different catalytic sites 
exist for attaching ADP-ribose initially to the acceptor and for subsequent 
elongation.
The presence of multiple ADPR transferase enzymes was initially shown by the 
differing reports of molecular mass of calf thym us ADPR transferase purified by 
different laboratories (Tsopanakis et al., 1978, Jongstra-Bilen et al., 1981). However, 
Jonstra-Bilen et al. (1981) and Holtlund et al. (1981) found no evidence of tissue or 
species specific differences in molecular mass of the enzyme from amongst tissues of 
rat liver, pancreas and bovine brain and kidney. Agemori et al. (1982) suggested 
that species or tissue specificity of ADPR transferase might exist, based on amino 
acid composition differences between mouse testicle and calf thymus. The 
molecular weight of the purified enzyme was shown to vary from 62 kDa in pig 
thym us (Tsopanakis et al., 1978) to 130 KDa in calf thym us (Yoshihara et al., 1978). 
The molecular mass of 62 KDa is reported to be an underestimate since it has been 
shown that it is subject to highly specific endogenous proteolytic processing 
(Holtlund et al., 1983a). Holtlund et al. (1981) compared the molecular masses of 
ADPR transferase in HeLa cells and pig thym us and found them to be identical at 
112 KDa, a view supported by Kawaichi’s finding that the purified rat liver enzyme 
is 110 kDa (Kawaichi et al., 1980). Results obtained from Kameshita et al. (1984) 
using limited chymotryptic digestion has shown that the enzyme can be cleaved into 
3 distinct domains of 54, 46 and 22 KDa; respectively capable of binding NAD, 
DNA and of accepting ADP-ribose. Further study using plasm into cleave the 
enzyme revealed that the DNA binding site is in the N-terminal peptide and that the 
C-terminal peptide contains the NAD binding site (Buki and Kun, 1988).
- 1 0 -
The isolation of partial or fu ll length cDNA clones encoding the human enzymes has 
provided new information on the enzyme structure. Human fibroblast ADPR 
transferase cDNA contains an open reading frame for a 1014 amino acid polypeptide 
corresponding to a calculated molecular weight of 113 KDa. The amino-terminal 
DNA- binding domain is highly basic and contains two homologous sequences 
(amino acid positions 2-97 and 106-207). These conserved sequences contain two 
putative zinc-binding motifs (Uchida et al., 1987, Kurosaki et al., 1987) which are 
probably involved in the interaction with DNA. It was also found that there is a 
high content of lysine and glutamic acid residues in the automodification domain 
with same short repeats of Glu-Val-Lys in the central part of the molecule. 
Furthermore, it was shown that the N-terminal portion of the 46 KDa fragment 
specifically binds 65Zn as well as nick-translated DNA in Southern-Western blot 
experiments (Mazen et al., 1988).
When ADPR transferase activity is increased, it also modifies chromatin structure 
and affects the enzymatic activity of other enzymes. Various enzymes are inhibited 
following ADP-ribosylation such as topoisomerases I and II (Ferro and Olivera,
1984) Ca2+, Mg2+ endonuclease (Yoshihara et al., 1975) and DNA polymeraseOCand J3 
(Yoshihara et al., 1985). In contrast to the above, DNA ligase activity was found to 
be stimulated in the presence of poly (ADP- ribose) (Ohashi et al., 1983) or by 
ADP-ribosylation (Creissen and Shall, 1982).
1.1.4 PROTEIN ACCEPTORS OF ADP-RIBOSYLATION
A variety of proteins have been identified as acceptors of ADP- ribosylation. 
Among these, both histones and non-histone proteins have been identified. Histones 
HI and H2B are the main acceptors of the monomeric or small oligomeric
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modification (Kawaichi et al., 1981a). ADPR transferase is a main acceptor of large 
polymers in vitro (Ogata et al., 1980) and in vivo (Kreimeyer et al., 1984). In the 
nuclei of the cellular slime mould Physarum polycephalum histone HI is found to be 
a major acceptor protein (Poirier et al., 1987).
Other proteins and enzymes have been found to be acceptor proteins, amongst these 
are the Ca2+, Mg2+ dependent endonucleases (Tanaka et al., 1984), DNA 
Topoisomerase I (Ferro and Olivera, 1984), RNA polymerase I (Taniguchi et al.,
1985), terminal deoxynucleotidyl transferase (Tanaka et al., 1986) and seminal 
ribonuclease (Suzuki et al.. 1986). P1, P4 - BiS (5‘-adenosyl) tetraphosphate 
(Ap4A), which is thought to be a positive growth signal and a trigger for DNA 
replication (Grummt, 1978), can be modified by ADP-ribosylation in vitro provided 
that Ap4A is attached to protein (Yoshihara and Tanaka, 1981). In a mouse 
hepatoma cell line (Hepa), an 80-KDa protein, (P80) was found to be an acceptor 
protein under conditions of essential amino acid starvation (Ledford and Jacobs.
1986).
Recently, M atsuura et al. (1988) have reported that in vitro, L- type pyruvate 
kinase purified from pig liver can serve as an acceptor for ADP-ribosylation by hen 
liver nuclei ADPR transferase and that this modification results in suppression of 
the subsequent phosphorylation by cAMP-dependent protein kinase.
Some of the links between ADP-ribose and its protein acceptors are via an ester 
bond between the C-l hydroxy group of the distal ribose on an initial ADP-ribose 
moiety and the carboxy group of glutamic acid, or a terminal lysine residue (Burzio 
et al., 1979; Adamietz and Hilz, 1976). These ester linkages are sensitive to 
hydrolysis in either neutral hydroxylamine or alkali. In contrast, some links are
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hydroxylamine and/or alkali resistant (Kawaichi et al., 1981b).
1.1.5 INHIBITORS OF ADPR TRANSFERASE
A major approach in the investigation of the involvement of ADP- ribosylation in 
cell structure and function has been to determine the physiological effects of ADPR 
transferase inhibitors. Thus they are widely used in defining a role for nuclear 
ADP- ribosylation. Early reports showed that NADH, a-NAD and NAD analogues 
significantly inhibited enzyme activity at concentrations equimolar to the substrate 
(Preiss et al., 1971; Hilz et al., 1974). Nicotinamide has been observed to be a 
competitive inhibitor of the enzyme (Fujimura et al., 1967; Preiss et al., 1971). 
Various analogues such as benzamide (Shall. 1975), pyrazimide (Khan. 1977) and 
picolinamide (Sim et al., 1982) are also good inhibitors. Thymidine is a good 
inhibitor as is its close analogue 5-bromo-2 - deoxyuridine (Preiss et al., 1971). 
Other compounds were also reported to be ADPR transferase inhibitors eg 
methylated xanthines, cytokinine (Levi et al., 1978); theophylline, theobromine and 
caffeine (Haldorsson et al., 1978). 3-Aminobenzamide, 3- methoxybenzamide 
(benzamide analogue) and 3-acetamidobenzamide (3- aminobenzamide analogue) 
(Purnell and Whish, 1980) are the latest ADPR transferase inhibitors introduced. 
These are widely used in many laboratories as tools to probe for the biological roles 
of nuclear ADP-ribosylation.
The intact carboxamide group of nicotinamide or picolinamide is essential for 
effective inhibition as shown by the dramatic disappearance of inhibition effect if 
the carboxamide group is modified to 3-acetyl or N-methyl carboxamide or N.N 
dimethyl carboxamide. More evidence that the intact carboxamide group on an 
aromatic parent ring is vital for inhibition was demonstrated in benzamide and
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pyrazinamide. Purnell (1980) found that 3-aminobenzamide is more effective than 
benzamide, but 3-aminobenzoic acid is not. Substitution of the benzene ring with 
amino groups at position 2 or 4 decreases the inhibitory effect, 2-aminobenzamide 
and 4- aminobenzamide are less effective than 3-aminobenzamide and benzamide 
respectively. Substitution of a methyl group on the ring nitrogen as in 1- 
methylnicotinamide caused a large increase in ADPR transferase inhibition. 
Furthermore, it was also demonstrated tha t compounds in which the ring is 
completely saturated cause no inhibition eg nipecotamide and isonipecotamide (Sims 
et al., 1982). These results indicate that a planar aromatic ring system is required 
for binding to the ADPR transferase. Another factor which may affect enzyme 
inhibition binding is the number and position of the methyl group on the xanthine 
ring as it was shown that the order of efficiency of methylxanthines was 
theophylline > theobromine > caffeine w ith ki values of 15.2, 29.8 and 244 
respectively (Claycomb, 1976).
The majority of ADPR transferase inhibitors lack physiological specificity; 5- 
methylnicotinamide, thymidine and its analogues and the methylated xanthines 
affect many cellular processes other than ADP-ribosylation. For example, 
nicotinamide is a substrate for NMN pyrophosphorylase and may deplete the 
cellular phosphoribosylpyrophosphate pool (see figure 1) as suggested by Hilz’s 
group (Liber et al., 1973). Furthermore, nicotinamide, thymidine and methylated 
xanthines have all been shown to inhibit NAD glycohydrolase activity in rabbit 
reticulocytes (Webb, 1966; Wu et al., 1978). Skidmore et al. (1979) reported similar 
results for 5-methylnicotinamide and theophylline in L1210 cells. Methylated 
xanthines also inhibit cAMP phosphodiesterase (Levi et al., 1978). Grunfeld and 
Shigenaga (1984) found that nicotinamide and benzamide inhibit deoxyglucose 
uptake in differentiated 3T3-L1 fat cells. This finding was confirmed by Schechter
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(1984) who reported that nicotinamide inhibits basal and insulin stimulated 
lipogenesis in rat fa t cells and that most of the lipid found in adipocytes was 
synthesized from glucose (Kuri-Horcuch et al., 1978). Thus any alteration of 
cellular processes observed on treatment of cells with the above compounds can not 
be ascribed directly to inhibition of ADPR transferase.
The specificity of 3-aminobenzamide, 3-methoxybenzamide and 3- 
acetamidobenzamide has also been challenged by various workers. The Cleaver 
group reported that 3-aminobenzamide caused a disturbance in purine metabolism 
(Cleaver et al., 1983) and tha t it may affect other metabolic processes such as DNA 
synthesis, glucose metabolism and cell viability (Milam and Cleaver, 1984). Recent 
reports using the HPLC separation of the deoxynucleosides procedure has shown 
that 3-aminobenzamide exhibits a wide range*effects on DNA precursor metabolism, 
such as the enhancement effect of 3- aminobenzamide on [3H] deoxycytidine 
incorporation into DNA relative to the other three deoxynucleotides. The 
incorporation of radioactivity from [3H] glucose into the pyrimidine moiety of the 
bases in DNA was significantly inhibited by 3-aminobenzamide relative to 
incorporation into the purine fraction. A major inhibitory effect on the 
incorporation of the methyl group from [3H] methionine into the deoxynucleotides 
reflects the metabolism of the one-carbon pool, thus involving the metabolic 
pathways of tetrahydrofolic acid, glucose and phospholipids (Milam et al., 1986).
Results obtained from other groups however are contradictory to the above. Ben- 
Hur et al. (1985) studied the enhanced radiation lethality of Chinese hamster cells 
using high concentrations of ADPR transferase inhibitors but only for short periods 
(2 h). Although results show some relatively small effect on the metabolism of 
glucose and on the synthesis of DNA, they suggested that these perturbations are
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not correlated with an enhanced radiation response which, itself, was found to be 
due to the potency of the inhibition of poly (ADP-ribose) synthesis. Berger et al. 
(1987) have also demonstrated that the predominant effect of 3-aminobenzamide on 
mitogen stimulated human T lymphocytes is on ADP-ribosylation. Eventhough 3- 
aminobenzamide affected the rate of glucose utilization, the levels of ATP in cells 
were maintained close to those observed in cells treated with mitogens alone.
Discrepancies were demonstrated earlier by Hdting et al. (1985); their results 
showed that inhibition of ADPR transferase causes little or no growth inhibition 
and has no effect on purine or pyrimidine nucleotide synthesis de novo. The 
inhibition effects of ADPR transferase inhibitors on glycine incorporation into ATP 
and GTP and on thymidine incorporation into DNA were suggested to be related to 
an inhibition of ADP-ribose or that it may be a secondary effect of the inhibitors.
1.1.6 CELL CYCLE AND ADP-RIBOSYLATION
It was reported earlier that ADPR transferase activity was low in S phase and high 
in G2 phase (Hilz and Stone, 1976; Purnall et al., 1980). Recently, Leduc et al. (1988) 
have used an immunological and biochemical approach to study the properties of 
ADPR transferase during the cell cycle progession of G j, S and G2+M in rat FR 3T3 
fibroblasts. This method is an alternative procedure to avoid possible artifacts due 
to classical methods of synchronizing cells which use drug treatm ent or deprivation 
of essential growth factors. Results confirmed tha t enzyme activity increased at the 
Gj/S boundary and reached a maximum in G2 and M phase. These results suggest a 
cell-cycle activation of enzyme which occurs in the G2+M phase. Moreover, it was 
shown that quiescent cells showed a lower content of ADPR transferase than cells 
in Gj phase.
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FIGURE 4 .a Inhibitors o f ADPR transferase.
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FIGURE 4.b Inhibitors of ADPR transferase and their acid 
analogues used in this thesis.
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Using [32P] NAD incorporation in permeabilized cells, Holtlund et al. (1980) had 
shown that ADPR transferase exists in metaphase chromosomes. The same group 
reported that the increase in poly (ADP-ribose) occured mainly on histone HI, not 
non-histone protein in metaphase and interphase arrested HeLa S3 cells (Holtlund et 
al., 1983b). This phenomenon was similar to that shown in the results from 
Tanuma and Kanai (1982).
Adolph and Song (1985) investigated the basic differences in the ADP-ribosylation 
of non-histone protein from interphase nuclei and metaphase chromosomes in the 
HeLa cell genome. Results showed that the main acceptors of the [32P] labelled 
NAD were from interphase. Further results from in vivo studies have shown that 
histones H2B, H2A and H4 were the predominant acceptors of the [3H] adenosine 
label in interphase nuclei and that ADPR transferase was the only major acceptor 
for metaphase chromosomes (Adolph, 1987a). It was suggested that chromatin 
fibers of metaphase chromosomes are highly condensed in comparison to nuclei and 
the decrease in ADP- ribosylation at mitosis could be caused directly by the 
compaction of chromatin, making the proteins inaccessible to ADPR transferase. 
Furthermore, the higher degree of nicking DNA during interphase might stimulate 
the increased modification of nuclear proteins (Adolph, 1987b).
1.1.7 DNA METABOLISM AND GENE EXPRESSION
Chromatin structure plays an important role in the control of gene expression in 
eukaryotic cells (Eissenberg et al., 1985) and ADP-ribosylation has been shown to be 
related to DNA metabolism and gene expression. Tanuma and Johnson (1983) 
reported that glucocorticoid treatm ent of mouse mammary 341 tum our cells 
decreases ADP-ribosylation of various nuclear proteins, especially of HMG14 and
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17, concurrent with the induction of mouse mammary tum our virus gene 
expression. A decrease in ADP-ribosylation of HMG14 and 17 could cause subtle 
changes in chromatin structure making promotor regions more accessible to RNA 
polymerase II, the important enzyme in the regulation of eukaryotic gene expression 
(Manley et al., 1980; Weil et al., 1979). Furthermore, the same groups (Tanuma et 
al., 1987) have demonstrated that 3-aminobenzamide, an inhibitor of ADPR 
transferase has the same capacity as dexamethasone (a synthetic glucocorticoid) to 
induce the synthesis of metallothionein and that the inductions of metallothionein 
were temporarily correlated w ith a decrease in the amount of endogenous poly 
(ADP-ribose) on non-histone HMG14 and 17.
The effects of steriod hormones on ADP-ribosylation are also of interest as these 
hormones are clearly established as being able to influence gene expression. It was 
reported that testosterone deficiency induced by castration was found to lead to a 
decrease in total ADP-ribose residues in mouse kidney and it was restorable upon 
daily injection with the hormone (GarCmann et al., 1981). Oestrogen was found to 
stim ulate ADPR transferase in quail oviduct (Muller et al., 1974) and progesterone 
was found to induce ADPR transferase activity in Xenopus oocytes (Burzio and 
Koide, 1977).
Aubin et al. (1983) and Poirier et al. (1982) have shown that in vitro ADP- 
ribosylation caused the relaxation of the polynucleosome structure, presumably 
through its elfect on modification on histone HI. In addition to this discovery, in 
vivo studies have shown that the activity of topoisomerse I, an enzyme implicated in 
DNA replication, transcription and modification of chromatin structure (Gellert, 
1981) was decreased in parallel to the extent of its ADP-ribosylation (Jongstra-Bilen 
et al., 1983). This evidence has suggested that the involvement of ADP-ribosylation
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is related to DNA metabolism and gene expression in vivo through alterations of the 
chromatin structure.
Further evidence was shown by Sastry and Kun (1988) who suggested that binding 
of poly (ADP-ribose) to DNA and nucleosome could have a localized effect on the 
topology of DNA which may indirectly influence gene expression. Recently it has 
been reported that a significant portion of endogeneous poly (ADP-ribose) is tightly 
associated w ith the nuclear matrix (Cardenas-Corona et al., 1987), a major ADP- 
ribosylation site w ithin the nucleus, in which the metabolic reaction may be closely 
connected with the events modulating DNA replication (Alvarez-Gonzalez and 
Ringer, 1988). It was found that nuclear matrix contains an active fraction of DNA 
replication enzyme complexes (Tubo and Berezney, 1987).
1.1.8 CELLULAR DIFFERENTIATION
Caplan and Rosenberg (1975) were the first to demonstrate that ADPR transferase 
was involved in cellular differentiation using mesodermal cells of embryonic chick 
limb buds, since these cells have the ability to differentiate into muscle or cartilage. 
The authors showed that the NAD levels fluctuated during differentiation. Later 
Yong and Sweeny (1978) showed a decreased incorporation of adenosine in mouse 
ova during and after fertilization.
The precise mechanism for the involvement of ADP-ribosylation in cell 
differentiation is still unclear. It is not certain whether DNA strand breaks or 
chromatin structural changes resulting in an increased availability of ADP-ribose, 
are responsible for these changes in enzyme activity. Some drastic changes in ADP- 
ribosylation which may affect cytodifferentiation could not be ascribed to DNA
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strand break and the signal prompting these changes has not been identified (Brae et 
al., 1985). It is possible that these alterations in the level of ADP-ribosylation 
reflect the varying availability of NAD during cytodifferentiation.
Farzaneh et al. (1982) and Johnstone and Williams (1982) suggested that 
spontaneous DNA strand breaks are responsible for activating the ADPR transferase 
activity during early differentiation events in chick myeloblasts and human 
lymphocytes. Farzaneh et al. (1987a) have reported that during the induced 
differentiation of the human promyelocytic leukemic cell line, HL 60, strand-breaks 
are formed and transiently maintained along the myelocytic lineage DNA before 
being religated and tha t such processes require ADPR transferase. The same group 
has also demonstrated that the efficiency of DNA repair is the same both in the 
differentiated and undifferentiated HL 60 cells (Farzaneh et et al., 1987b). Results 
from Hacham and Ben-Ishai (1984) and Althaus et al. (1982b) are contradictory to 
the above findings. They reported that transient and spontaneous alterations in 
ADPR transferase activity in prim ary hepatocyte cultures are not causally related 
to DNA fragmentation. Furthermore, Jackowski and Kun (1981) found age- 
dependent variations in ADPR transferase activity in cardiocyte nuclei in the 
absence of measurable DNA fragmentation.
More evidence was based on ADPR transferase inhibitors. They were found to 
prevent the induction of adipocytes (Lewis et al., 1982) and Friend cell 
differentiation (Terada et al.. 1979). In Drosophila melanogaster, ADPR transferase 
inhibitors have been shown to retard development, kill larvae in a dose-dependent 
manner and induce mitotic recombination in response toT  irradiation (Ferro et al., 
1984). Suzuki et al. (1987) have shown that RNA expression of ADPR transferase 
decreased during the granulocytic differentiation of HL 60 cells upon induction by
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retinoic acid. Furthermore, the levels of the enzyme molecule and mRNA for the 
ADPR transferase were reduced by 50% of the original during nerve growth 
factor-promoted neurite outgrowth in rat pheochromocytoma PC12 cells. These 
results suggested tha t the decrease of ADPR transferase activity may be due to a 
reduction in gene expression. This result suggests that such reduction seems to be 
required for some cellular differentiation (Taniguchi et al., 1988).
1.1.9 DNA REPAIR
Roitt (1956) was the first to show that treatment of cells w ith alkylating agent 
induces cellular NAD depletion and subsequently prevents glycolysis. Later, Simse* 
al. (1983) demonstrated that NAD depletion is followed by a dramatic decrease in 
ATP levels causing a reduction in ATP-dependent functions leading eventually to 
cell death. Whish et al. (1975) and Smulson et al. (1975) have reported 
independently that DNA damaging agents stimulated the activity of ADPR 
transferase followed by a decrease in cellular NAD level. These observations 
provided a rational explanation for the drop in cellular NAD and a suggestion that 
poly (ADP-ribose) may be involved in the cytotoxic effects of alkylating agents.
The dependency of poly (ADP-ribose) synthesis on DNA strand breakage has been 
extensively reported (Berger et al., 1979; Benjamin and Gill, 1980a and Jacobson et 
al., 1983). The type of break introduced into the DNA duplex is important in 
regulating ADPR transferase activity. Double-stranded restriction fragments with 
flash ends are reported by Benjamin and Gill (1980b) as being most effective, three 
times more so than DNA fragments with 3’ extensives which are more than three 
times as effective as DNA w ith unpaired nucleotides extending from the 5’ termini 
or DNA w ith single strand breaks.
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A role for poly (ADP-ribose) in DNA repair has been suggested by Durkacz et al. 
(1980a, b) who found that 3-aminobenzamide or 5- methylnicotinamide retarded 
the rejoining of DNA strand breaks induced by dimethyl sulphate (DMS) in mouse 
L1210 cells. Furthermore, ADPR transferase inhibitors were also found to inhibit 
the decrease in cellular NAD levels normally seen following DMS treatment in the 
absence of inhibitors. The same group also showed that ionizing radiation has little 
or no effect on the NAD level in these cells (Nduka et al., 1980). These results were 
supported by James and Lehmann (1982). However, Zwelling et al. (1982) reported 
that both 3-aminobenzamide and 5-methylnicotinamide slowed but did not prevent 
the rejoining of x-ray induced DNA strand breaks in L1210 cells. These results 
suggested that x-ray break rejoining may happen in two ways, one associated with 
poly (ADP-ribose) synthesis and the other independent of its synthesis. James and 
Lehmann (1982) also suggested that the effectiveness of different agents at inducing 
poly (ADP-ribose) synthesis may be related to the level of DNA breaks induced. 
At an equitoxic dose, an alkylating agent w ill produce five times as many breaks as 
ionizing radiation and ten times as many as UV radiation (Shall, 1984).
Some reports however, claimed tha t ADPR transferase inhibitors stimulated strand 
rejoining after exposure to alkylating agents or UV light in human lymphoid cell 
types (Bohr and Klenow, 1981; Althaus et al., 1982a).This authors suggested that the 
differences may be that the influence of such inhibitors on DNA repair is dependent 
on the agent used initially to stim ulate the repair synthesis together w ith possible 
differences in cell membrane permeability to the inhibitors. Furthermore, there 
may be substantial differences in the kinetic parameters of the several steps in DNA 
repair which contribute to the observed differences in responsiveness to ADPR 
transferase inhibitors in various cell lines. These observations were supported by 
D urrant and Boyle (1982) who found in rodent cell lines that the enhancement of
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cytotoxicity by ADPR transferase inhibitor is cell line dependent.
It is now accepted that ADP-ribosylation is involved in DNA repair though its exact 
role remains unclear. It was first postulated that the ADP-ribosylation is necessary 
for fu ll activity of the DNA ligase step that is. the final step, of DNA repair (Shall, 
1984). This was concluded from data showing a higher steady state concentration of 
DNA strand breaks in alkylated cells when ADPR transferase inhibitors were 
present (Ohashi et al., 1983). Criessen and Shall (1982) have suggested that DNA 
ligase II is involved in the process as they found, in vitro, the direct modification of 
DNA ligase II. However, the in vivo experiments have failed to demonstrate a 
modification of the DNA ligase by poly (ADP-ribose) (Kreimeyer et al., 1984; 
Adamietz and Rudolph, 1984). Some reports suggest that such higher steady state 
concentrations of DNA strand breaks in alkylated and ADPR transferase inhibitors 
compared to alkylated cells alone do not necessarily result from a slow-down of the 
repair rate. It was suggested that it could be the consequences of a higher number 
of incisions either by repair endonucleases or by endonucleases not directly 
involved in DNA repair eg Ca2+/Mg2+ dependent endonuclease, which increased 
DNA breaks by further cutting (Wielckens et al., 1985).
Cleaver and Morgan (1985) have suggested that poly (ADP-ribose) does not regulate 
the ligation stage of repair. Their results have shown that the direct measurement 
of the rate of ligation of intracellular repair patches and of the size of repair patches 
are unchanged when ADP-ribosylation is inhibited. They argued that if the process 
of ligation is delayed by inhibition of poly (ADP- ribose) synthesis, continued 
repair polymerization should therefore generate longer repair patches. This notion 
was supported by Collins (1987) who blocked repair synthesis in UV treated 
hamster cells w ith inhibitors of repair synthesis. They reversed the inhibition
- 2 5 -
processs and investigated the ligation process of excision repair using an ADPR 
transferase inhibitor. Results showed that 3-aminobenzamide does not delay the 
rejoining of the DNA break. Furthermore, some reports have even suggested that 
3-aminobenzamide actually stimulated ligation of repair patches (Cleaver and Park,
1986). If used at very low concentrations (0.01-0.1 mM) it was found to reduce 
strand-break frequencies and increase repair replication in human lymphoid cells 
damaged by MMS (Cleave and Morgan, 1987).
In contrast to the above, Hunting and Gowans (1987) reported that 3- 
aminobenzamide inhibited ligation of repair patches in normal human fibroblasts 
following UV irradiation. Their experiment was different from Collins’ (1987) in 
that it was not carried out in the presence of inhibitors of repair synthesis as they 
were shown to reduce NAD concentration. However, UV radiation alone did not 
lower NAD concentration. This finding led to the suggestion that the results 
obtained from Collins (1987) and Cleaver and Park (1986) which show high levels 
of strand breaks while using inhibitors of repair synthesis to determine the effect of 
3-aminobenzamide on repair, may give misleading results since poly (ADP-ribose) 
synthesis may already have been inhibited by the depletion of NAD.
The studies on chromatin structure in cells cultivated in the presence of benzamide 
have indicated that ADP-ribosylation is involved in the organisation of chromatin 
structure, which allows correct repair of DNA following alkylation (Wielckens et 
al., 1985). One example is the relaxation of chromatin caused by the ADP- 
ribosylation of histone HI (Poirier et al., 1982; Aubin et al., 1983). This could 
permit excision of DNA lesions by making the relax regions more accessible to the 
repair enzyme. Reports obtained from Neidergang et al. (1985) have also suggested a 
potential role for poly (ADP-ribose) in DNA replication and repair as it was shown
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that decondensed ADP-ribosylated polynucleosomes were a better template for 
DNA polymerase. De Murcia et al. (1985, 1986) observed that under poly (ADP- 
ribose) turnover conditions, local chromatin remained in a decondensed form. 
Creation of these open chromatin regions may be the key modification in which poly 
(ADP-ribose) is necessary for the DNA repair processes as postulated by Mathis and 
A lthaus (1987).
Recently. Loetscher et al. (1987) reported that the level of post-translation by poly 
(ADP-ribose) modifications of chromatin proteins in mammalian cells is related to 
the availability of NAD which varies in different physiological and pathological 
states. Loetscher suggested that poly (ADP-ribose) may serve as a signal which 
alters metabolic conditions involved in chromatin and thus modulates its functions 
in accordance w ith a change in metabolic state.
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PART II
1.2.1 TYPES OF GENETIC CHANGES
Gene mutation is a heritable change in the nucleotide sequence of DNA or of its 
genoming RNA (in the case of RNA viruses). This change may be expressed, for 
example, as a change in structure of a protein which alters or abolishes its enzyme 
properties. Changes in the content or arrangement of information in DNA can occur 
in a single nucleotide within a codon or in the number of complete chromosomes in 
a genome. There are three general types of mutation; point, chromosomal and 
genomic mutation. (Venitt and Parry, 1984)
Point mutations are changes in nucleotide sequence in one or few codons and these 
can occur by base substitution, deletion or addition. Additions or deletions can 
change the reading frame of DNA and when this occurs, they are known as 
frameshift mutations. The change of codon may lead to the insertion of the wrong 
amino acid into the polypeptide. If this occurs at a critical site in a polypeptide, this 
may inhibit its function eventually leading to partial cell growth, or it may cause 
an increase in temperature sensitivity rather than a total loss in function. The 
change may also lead to the conversion of a codon normally specifying an amino 
acid to one which is a terminator codon. This causes polypeptide synthesis to stop 
prematurely with the production of defective proteins containing short polypeptide 
fragments. Point mutations are usually detectable by the effects of the expression in 
the m utant cell or individual as a change in phenotype.
Chromosomal mutations are recognised as morphological alterations in the gross 
structure of chromosomes. They occur during breakage and reunion of
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chromosomal material during the cell cycle. It may happen as inversions (a length 
of chromosome is inserted back-to-front) or translocations (one section of 
chromosome becomes attached to another at the wrong place). This type of 
mutation normally has dramatic consequences for gene expression, most of which 
are lethal to the individual.
Genomic mutations are the changes in the number of chromosomes in the genome. 
The normal diploid (W ild-type) contains a complete set of chromosomes from each 
parent. Polyjlbidy occurs where the diploid genome is doubled or tripled. Loss or 
gain of a single chromosome is known as aneuploidy, the addition of one 
chromosome is trisomy and deletion of one chromosome is monosomy.
From the time that mutation was emphasized by de Vries (1901) as a fundamental 
genetic process, its analysis has been one of the most important areas in research. It 
was recognized as the cause of modified genes which constitute the raw material for 
evolution and which are subject to natural selection. This is such a crucial process 
that modern definitions of life include m utability as a fundamental property of 
living organisms.
Mutations may occur spontaneously or may be induced by physical and chemical 
agents (Singer and Kusmierek, 1982). The first of several major advances in the 
analysis of mutational process was discovered by Muller (1927) who demonstrated 
that mutation could be induced in Drosophila using x-ray irradiation. This was 
eventually broadened to include mutagenesis by chemical agents (Auerbach and 
Robson, 1947). If the frequency of spontaneous mutations is too low for convenient 
experimentation, mutagens can be used to increase the frequency of m utants in 
culture at 10 to 1000 times the spontaneous frequency. Mutagens increase the
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frequency of impaired bases escaping repair and thus leads to the change in the 
original sequence of DNA (Roberts, 1978; Lawley, 1974).
Although cell culture and m utant isolation procedures are slow due to the length of 
time required to obtain results, the progress of somatic cell genetics has developed 
into a recognized discipline. This is largely because of the development of methods 
for isolation of a variety of m utant phenotypes and the technology for 
manipulating the m utant gene in order to study the consequences of the changes.
1.2.2 REPLICA PLATING AND CLONING
Replica plating is useful for isolating m utants which can not be isolated by direct 
selection, for example, in cells expressing a conditional lethal phenotype such as 
temperature sensitivity or cells expressing or failing to express specific antigens. 
The technique screens large numbers of individual clones of cells for the phenotypes 
of interest while still maintaining a master copy of the colonies. This involves 
plating 100-400 cells per dish and applying one of a variety of materials eg filter 
paper, nylon or polyester cloth on top of the colonies so that some but not all of the 
cells from each of the colonies are transfered to the material from the dish. The 
replica can be screened for the desired phenotype while the master is maintained. 
When the copy of interest is identified by a particular assay, then one can return to 
the master dish and isolate cells from that colony. In this way, any test can be used 
to screen a population without requiring a selection by cell killing for the desired 
phenotype (Gal, 1987).
Methods for isolating single cells and propagating them into a population of cells are 
called cloning and the majority of them fall into one of the three categories of
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techniques
1) Diluting techniques. This can be done using microtest plates containing 96 
wells, each well holding up to 0.4 ml. A single cell can be added (diluted with 
sufficient volume of medium to give 10 cells/ml) in 0.1 ml of medium per well and 
thereby provide the individual cell w ith its own culture dish and with a sufficiently 
small amount of fluid to minimize the conditioning factors (Robb, 1970; 1973).
2) Cloning of Anchorage - Dependent cells. The cells are seeded onto 6 cm tissue 
culture dishes or petri dishes coated with either collagen or fibrin (Reid and 
Rojkind, 1979). By seeding only 100-200 cells per plate, large colonies of cells can 
be obtained that are sufficiently separated to permit the isolation of individual 
colonies (Schmitt and Maroudas, 1974).
3) Cloning of Anchorage - Independent cells. Dilute concentrations of cells are 
seeded into medium solidified by agar or agarose. Cells capable of growing in 
suspension in the agar medium form colonies (Puck et al., 1956).
1.2.3 ISOLATION OF MUTANTS AND THEIR RELATED EFFECTS
In order to broaden the knowledge of the genetics and physiology of mammalian 
cells, a large variety of cells carrying defined genetic markers must be available. 
The selective procedures that have been worked out are those for obtaining cell lines 
with a particular nutritional deficiency (auxotrophic m utants), w ith conditional 
lethality (tem perature- sensitive) and with resistance to any of a variety of drugs 
( drug-resistant).
-31  -
Auxotrophic mutations are well suited to mapping synthetic pathways. Drug- 
resistance markers provide a means to study the properties of a target molecule in 
terms of its role in normal cell function. Conditional lethal mutations are useful 
for the study of the regulation. When the lethality is temperature-sensitive (ts), 
there is a potential for correlating the elfects of temperature shift on cellular 
properties with changes in the functional or structural integrity of an isolated 
molecular component. M utants therefore provide a means of evaluating the 
biological importance of enzymes or other proteins which can be isolated and 
characterized in vitro.
Auxotrophic m utants and conditional (mainly temperature- sensitive) m utants 
must be isolated either by nonselective procedures such as replica plating or by 
lethal growth method. This involves the creation of a situation wherein the normal 
cells grow and are killed leaving behind the mutants, which can be rescued.
The selective agents that have been used to isolate auxotrophic and temperature- 
sensitive mutants, are ones that act during the S phase of the cycle. These are "DNA 
poisons" such as cytosine arabinoside (Thompson et al., 1970), 5 fluoro-2- 
deoxyuridine (FUdR) (Meiss and Basilico. 1972). the high specific activity of tritium  
[3H]-thymidine (Thompson et al.. 1970) or 5-bromo-2-deoxyuridine (BUdR) and 
light (Naha, 1969).
Procedures for succesfully isolating auxotrophic mutants using BUdR and light 
were first developed by Puck and Kao (1967). In this procedure, a population of 
cells, most of which display w ild-type growth characteristics w ith a few rare cells 
displaying additional m utant nutritional requirements, is placed in a selective 
medium. In this situation only the former but not the latter can grow. An agent,
- 32 -
such as BUdR, that w ill kill growing cells is then added to isolate different mutants 
(Kao and Puck, 1968; Puck and Kao, 1967). This procedure depends on the 
differential incorporation of the thymidine analogue (BUdR) into the DNA of 
dividing but not into non-dividing cells in a selective medium sufficient for growth 
of w ild-type but not m utant cells. After incorporation of BUdR, the cell culture is 
exposed to visible light and as BUdR is light sensitive, the w ild-type (dividing) cells 
are killed, leaving the m utant (non-dividing) cells. For details of this procedure see 
Patterson and Waldren (1987). These selection procedures have allowed for the 
isolation of a wide variety of m utants w ith new nutritional requirements 
(Patterson. 1985) or of m utants with altered temperature sensitivity (Patterson et 
al., 1976). Many of auxotrophic m utants have been analyzed biochemically and 
they have been shown to involve a single gene m utation resulting in absence or 
malfunction of a specific enzyme. Many different auxotrophic m utants defective at 
steps in the synthesis of purines and pyrimidine, cholesterol, unsaturated fatty  
acids, amino acids and carbohydrate metabolism have been isolated (see table 1). 
The rate of spontaneous m utation frequency for auxotrophic m utants is in the order 
of about xlO"6 (Kao and Puck, 1974).
For temperature-sensitive mutants, the conditions of killing wild-type at the 
nonpermissive temperature were used by incubating cells w ith "DNA poisons". This 
takes into account that under such conditions, w ild-type cells m ultiply normally 
while the m utants are arrested in some essential steps of their metabolism. 
Preferential killing of w ild-type cells enriches the population with mutants. The 
cells then shifted back to the permissive temperature to allow for growth of m utant 
cells. M utants that are temperature-sensitive for growth and that are blocked at 
specific points in the cell cycle enable specific control events in the cell cycle to be 
identified, for example, a Chinese hamster m utant blocked at Gj at 40 deg.C was
- 3 3 -




































Kao and Puck 
(1967; 1974)
Chasin et al. (1974); 
Law and Kao (1979)
Kao and Puck (1972)
Kao (1980)
Patterson (1975)









Uridine, orotic acid 
or dihydroorotic acid
Slower growth, not 
requiring uridine
Uridine
Unable to synthesize 
valine, leucine 



































































Kao and Puck (1975) 
Jones et al. (1980)
Taylor et al. (1971)
Chang and Vggelos
(1976)
Chang et al., (1977)
Jones and Puck (1973)
Taylor and Hanna
(1977)
McBurney and W hitmore




















in place of arginine




Unable to grow on 



















Faber and Deutscher 
(1976)
Thompson et al. (1975)
Naylor et <zZ. (1976)





























pur-1 Like ade Amidophosphori- 
bosy 1 transf erase
gin' Glutamine
ght Glycine- Folylpolygluta-
Meuth et al. (1979)
Kao and Puck (1972)
Onada and Matsushiro 
(1973)




Chu et al. (1969)















Sun et al. (1974)
Respiration-
deficient,












Goldfarb et al. 
(1977)
Arginine requirement 
can be satisfied by 
argininosuccinate 
but not by citrulline
Argininosuccinate
synthetase
C arritt et al. 
(1977)
- 39 -
found to be defective in glycoprotein synthesis (Tenner et al., 1977). The defect of 
temperature-sensitive m utants is usually attributable to a single amino acid 
substitution in a protein essential to this process. As a result of such mutations, the 
protein remains functional at low temperature, but it loses its biological activity at 
a higher temperature which does not affect the w ild-type gene product. Growth is 
then normal at low temperature, because the affected protein is stable under these 
conditions but at higher temperatures no growth is observed. (Siminovitch. 1981; 
Basilico. 1977) The rate of spontaneous mutation frequency for temperature 
sensitive m utants is in the order of 10“6-10'7 (Basilico and Meiss. 1974).
The use of radioactively-labelled precursors provides a powerful method for the 
selection of m utants defective in membrane transport and in metabolic pathways. 
This method, called radiosuicide, is highly selective as the substrate itself is the 
killing agent in w ild-type cells. The principle is based on the killing effects 
generated by the incorporation of radiolabelled precursor. Therefore, any m utant 
able to reduce the uptake and/or the metabolism of the radioactive toxic precursor 
will survive. The wide variety of cell lines derived from the application of this 
method demonstrates its usefulness as seen on table 2.
1.2.4 DRUG RESISTANT MUTANTS AND THEIR RELATIVE EFFECTS
The isolation of somatic cell mutants resistant to specific drugs w ith known 
specificity has proved to be the simplest way to produce specific mutations in genes 
which encode proteins of special interest. There are many advantages to the 
isolation of drug- resistant m utants as the drug targets the mutation to a specific 
protein or metabolic process. This allows initial biochemical characterization of the 
m utant to be much easier. Furthermore, it also permits the investigator to begin the
- 4 0 -
TABLE 2 Mutants isolated by radioactive- labeled precursors
M utant Phenotype Screening References
The glucose transport 2 Deoxy (3H) 
and Glycolytic defective glucose
Pouyssegur et al. 
(1980a)
Glucose oxidative (3H) Glucose
pathway defective
Franchi et al. (1981) 
Pouyssegur et al. (1980b)
Transport of neutral l)<-(m ethyl- 
amino acids defective (3H) Amino iso-
butyric acid 
2) (3H) Proline
Finkelstein et al. (1977)
Dantzig et al. (1982)
Unable to synthesize ( 14C) Choline 
phosphatidyl choline












Nakano et al. (1985) 
Nakano and Akamatsu 
(1985)
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genetic analysis of a system which would otherwise be complex.
Inhibitors that kill cells or arrest their growth can be used to select resistant 
mutants. Although several different mechanisms can mediate resistance, substantial 
evaluation of the biological activity or quantity of a protein mediating resistance is 
often but not always the direct target of the inhibitor.
One of the most frequent problems encountered when isolating drug-resistant
m utants is the high frequency of appearance of m ultidrug resistance. M ultidrug
resistant cell lines are typically resistant to the anticancer drugs vinblastive,
vincristine, actinomycin D and adriamycin, regardless of which of these was used
as a selective agent. When tested, they are also frequently resistant to a range of
c
other structurally  and funtionally varied substances such as colchicine, pyromycin 
and emetine (Ling et al., 1983; Gerlach et al., 1986).
The most direct selection of drug-resistant m utants is a single-step procedure 
whereby a large culture of wild-type cells are exposed to a cytotoxic drug. The 
survival clones of drug-resistant phenotypes are then isolated. (This method is used 
in this thesis and employs an inhibitor of ADPR transferase as a cytotoxic drug). 
This procedure simplifies the characterization of the m utant since only one 
biochemical target should be involved in generation of phenotype. In order to 
isolate single-step mutants, it is necessary to choose the minimum concentration of a 
drug which will kill the great majority of cells and leave only the genetically 
resistant population. To obtain cell lines resistant to a high concentrations of a 
drug, it may be possible to extend the single-step isolation procedure to a multistep 
or a continuous selection. Successive increments in drug resistance might be 
obtained simply by submitting the cell population to consecutive single step
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selections with gradual increases in drug concentration or maintaining a mass 
population under continuous selection pressure. They are then maintained in a 
gradually increasing inhibitor (drug) concentration, until cells w ith a satisfactory 
degree of resistance overgrow the culture or are frequent enough to be isolated at a 
low cell density. A disadvantage of this procedure is the difficulty of evaluating the 
number of m utant alleles or loci that might be necessary to produce the selected 
phenotype, since the frequency of m utant phenotypes in the w ild-type population 
can not be measured directly.
The range of genetic mechanisms such as point mutation, deletion, duplication, 
chromosome instability and the generation of additional DNA copies by gene 
amplification are involved in development of inhibitor resistance. The simplest 
form of genetic change that may be considered is a base substitution in a gene 
leading to an amino acid change in a protein involved in resistance. Some forms of 
change such as gene amplification may be reversible in the absence of any 
continuous selective pressure.
Many drug resistance m utants are well known and have been studied in great 
detail. A number of investigators have already isolated spontaneous m utant clones 
resistant to 8-azaguanine (or related purine analogues) by using single-step selection 
procedures (Littlefield, 1963; Chu and Mailing, 1968; Gillin et al., 1972). They have 
shown that resistance commonly arises from the loss of activity of the enzyme 
hypoxanthine-guanine phosphoribosyltransf erase (HGPRT) (Kit et al., 1963;
K
McKusick and Ruddle, 1977; Chinault and Ca^ey, 1984). An enzyme, adenine 
phosphoribosyltransf erase (APRT), the homologue of HGPRT, has also been studied. 
This enzyme is considered to be prim arily responsible for the recycling of purine 
bases into nucleotide pools. The adenine analogues such as diaminopurine,
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fluoroadenine have been used to select resistant lines which have lost APRT (Jones 
and Sargent, 1974; Chasin, 1974; Steglich and DeMars, 1982). Similarly, the 
pyrimidine analogue 5-bromodeoxyuridine (BrdU) has been used to select resistant 
lines which have lost thymidine kinase activity (Littlefield. 1965; Roufa et al., 
1973). A wide variety of other drugs have been used to select resistant phenotypes 
of somatic cells in culture (see table 3).
The simplest form of genetic change that may be considered is a base substitution in 
a gene, leading to an amino acid change in a protein involved in resistance. 
Simonson and Levison (1983) have demonstrated this by cloning cDNA for 
dihydrofolate reductase, the target enzyme for drug methotrexate (MTX), from a 
highly MTX-resistant mouse 3T6 subline. DNA sequencing showed that the 
m utation involved a single substitution of a guanine for a thymine, which resulted 
in the substitution of an arginine or a leucine at position 22 of the protein.
Point mutation is not the sole genetic change that can lead to the development of 
resistance to a drug or inhibitor. Further understanding of the molecular nature of 
resistance to purine analogues has come from the cloning of structural genes for the 
enzymes that may be altered during the development of resistance. Analysis has 
been made of changes in the hypoxanthine-guanine phosphoribosyltransf erase 
(HGPRT) gene that can lead to resistance to 6-mercaptopurine and 6- thioguanine 
(purine analogues). The cloned cDNA sequence has been used as a probe to identify 
changes in restriction fragments in this gene in resistance mutations.
Fuscoe et al. (1983) found that the reduced HGPRT activity of the two m utants 
derived from hamster cell cultures involved deletions of large sections of the gene, 
whereas results obtained from  17 other m utants of spontaneous and UV-induced
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TABLE 3 Drug resistant mutants (Stark and Whal, 1984)
Drug(s)
5-Fluorodeoxyuridine
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mutants have been shewn to be consistent with being point mutations. In addition. 
Turner et al. (1985) found that 57% of thioguanine-resistant human lymphocytes 
showed either deletions or amplifications of the HGPRT gene that were not 
detectable cytogenetically. Thus it has been shown that a variety of DNA changes 
can be involved and that different classes of genetic changes can be varied by 
different treatments.
Evidence for complex genetic changes being involved in purine analogue resistance 
came from an early study by Fox and Radacic (1978) which showed that selection 
for resistance to a single high dose of purine analogues produced stable resistant 
rodent cell lines; whereas selection for resistance following prolonged exposure to 
low levels of purine analogues led to very unstable resistant clones. This implies 
that the first procedure involved point mutation. Studies on the mutation in the 
gene for adenine phosphoribosyltransf erase (APRT) has shown that it requires the 
loss of two copies of the gene. The development of resistance can be a two-stage 
process. A high-frequency event (gene inactivation or deletion) can occur either 
preceded by or followed by a low frequency event namely base substitution (Simon 
and Taylor, 1983).
Repeated duplication of regions of DNA can lead to the production of multiple 
copies of certain genes and their flanking DNA sequences which is known as gene 
amplification (Stark and Wahl, 1984). The relative importance of gene resistance 
probably varies between drugs. Amplification of genes confering resistance to 
methotrexate and 5-fluorouracil has been found in tum ors and cell cultures (Clark 
et al., 1987). It was proposed by Schimke et al. (1986) that overproduction results 
from the accumulation of an increased capacity for the initiation of DNA synthesis 
in cells where DNA synthesis is partially inhibited but RNA and protein synthesis
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can continue. It therefore follows that drugs or treatm ents that preferentially 
inhibit DNA synthesis relative to RNA and protein synthesis are more likely to 
result in amplification events leading to resistance phenomena.
The rate of spontaneous mutation frequency for drug resistant mutants is in the 
order of lO 'M o 11 eg l-5 x l0 '6 for HGPRT deficient (O’Neill et al., 1977), 5x l0 -11 
for thymidine kinase deficient (Clive et al., 1972), 3xl0~6 for adenosine 
phosphoribosyltransf erase, and 5xl0~5 for dihydrofolate reductase (Brown et al.. 
1983)
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INTRODUCTION TO THE PROJECT
A variety of evidence suggests that some of the biological functions of ADPR 
transferase are associated w ith DNA repair, gene expression and differentiation. 
Such conclusions are based on results involving ADPR transferase inhibitors which 
are complicated by their other metabolic effects in mammalian cells. The 
elucidation of its function in biological systems would be greatly facilitated by the 
availability of cell lines w ith a deficiency in this enzyme. The identification of 
m utant cell lines defective in a particular enzyme activity has been a useful 
approach in identifying the function of some enzymes. Such an approach was 
demonstrated by Cleaver (1968) who observed that fibroblasts in culture derived 
from the skin of a human patient w ith the disease Xeroderma pigmentosum were 
defective in excision repair following exposure to UV irradiation. This resulted in 
the availability of m utant cells defective in their response to DNA damage.
The principal reason why m utants provide so powerful an approach to 
understanding cell function is that they allow a comparison of the abnormal state 
with the normal state under conditions of an isogenic background. By permitting an 
examination of the metabolic consequences of altering one particular component of 
the cell, a m utant serves as a tool for probing functional relationships. M utants 
may therefore be used as analogues to that of inhibitory drugs w ith the advantage 
that their specificity of action is much more certain.
This project has aimed at isolating spontaneous m utant L1210 cells resistance to the 
cytotoxicity of 3-acetamidobenzamide (3-AAB), an inhibitor of ADPR transferase. 
At the concentration used (5 mM), 3-AAB was shown to be too toxic to wild-type, 
hence there was a possibility that some m utants would arise as a result of
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alterations in poly (ADP-ribose) metabolism.
The m utant cells were isolated using a single-step method in which cells were 
plated in large numbers inasoft agar plate containing 5 mM 3-AAB. The individual 
clones grown in soft agar were picked and grown in suspension medium containing 
5 mM 3-AAB. Various assays (as described in following chapters) were carried out 
on 12 m utant cell lines together with their w ild-type cells. Their properties were 






2.1 INHIBITORS, THEIR ACID ANALOGUES, AND CYTOTOXIC AGENT
The following were synthesized by B. Hunt in this laboratory : 3-
acetamidobenzamide, 3-aminobenzamide and 3-acetamidobenzoic acid, whilst 3- 
nitrobenzamide, 3-amino benzoic acid, 3- nitrobenzoic acid and dimethyl sulphate 
(DMS) were purchased from Aldrich Chemical Company Ltd. U.K.
2.2 TISSUE CULTURE MATERIALS
Mouse lymphoma cells, strain L1210, used throughout this study, were obtained 
from Flow Laboratories, Irvine Scotland. The following components for the growth 
media were also obtained from the same source : RPMI 1640 growth medium (10 x 
concentration), L-glutamine (200 mM), penicillin-streptomycin (500 IU/ml and 
5000 Ug/ml respectively), donor calf serum (mycoplasma and virus screened), 
sodium bicarbonate (7.5%) solution, and trypan blue (0.5% w /v  in 0.85% saline), 
sterile petri dishes of 6 cm in diameter were purchased from Sterilin, Scotland.
2.3 RADIOACTIVE LIGANDS AND RADIOACTIVITY COUNTING
[3H] NAD was prepared from [3H]-ATP (Radiochemical centre Amersham, Bucks) 
by Dr W. J. D. whish according to the method of Ohtsu and Nishizuke (1971). 
[3H]-NAD was prepared in ethanol w ith a final specific activity of 23 mCi/timole 
and radioactive concentration of 1 mCi/ml.
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[Carbonyl - 14C] nicotinamide (53 mCi/mole made up to 10 juCi/ml w ith 100% 
ethanol was obtained from Radiochemical Centre Amersham, Buckinghamshire U.K.
[3H] 3-acetamidobenzamide (5.85 nCi/mole) was prepared in this laboratory by Dr 
Whish and B. Hunt in 100% ethanol (117 nCi/ml).
Optiphase was purchased from BDH Chemical Ltd. 3MM filter paper disc and glass 
fibre disc (GFC) were supplied by Whatman Ltd, Maidstone, Kent, U.K.
2.4. THIN LAYER CHROMATOGRAPHY
PEI cellulose thin layer sheets (20 cm x 20 cm) were obtained from Camlab, 
Cambridge. Standard marker for NAD was purchased from Boehringer 
Corporation, Lewis, Sussex.






All equipment and non-sterile components of growth medium such as bottles, tubes, 
plugged pasteur pipettes, plastic tips and double glass distilled w ater, were 
sterilized by autoclaving at 120 deg.Cfor 20 min. The pipettes for measuring volume 
were plugged with cotton wool and sterilized overnight in pipette canisters in an 
oven at 160 deg.C.
3.2 PREPARATION OF RPMI GROWTH MEDIUM (pH7.4)
Normal RPMI 1640 complete growth medium was prepared by diluting RPMI 1640 
10 x concentration with sterile double glass distilled water, 10% (v /v )  calf serum, 2 
mM glutamine, 0.2% (v /v ) sodium bicarbonate and 100 IU each of penicillin and 
streptomycin, stored at 4 deg.C and used w ithin one month. Medium used for the 
cloning assay containing 0.3% (w /v ) of agar was prepared by the same method as 
before and kept at 37 deg.C.
3.3 CELL CULTURE
Mouse L1210 cells were usually stored in liquid nitrogen. When required, these were 
thawed at 37 deg.C in a water bath and suspended in complete RPMI growth 
medium to a cell density of about 2xl05 cell/m l. A fter 18h, the dim ethyl 
sulphoxide remaining in the medium was removed by carefully aspirating the
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medium to low level leaving cells undisturbed and fresh medium was added. The 
growth of such culture was checked periodically to ensure that the doubling time 
was 12-13 h. All cell counting was performed using a modified Neubauer 
haemocytometer, which allows Sequent microscopic examination of cell 
morphology. A minimum of 40 cells were counted on each set of nine chambers 
and the reproducibility of cell counting was shown to be ±10%. L1210 cells enter the 
stationary phase (Go) at about lxlO6 cells/ml. The cell line was maintained by 
subculturing to a cell density of not less than 5xl04 cells/ml. Cells from cultures 
in mid-log phase were used for all experiments.
3.4.1 ISOLATION OF MUTANT L1210 CELLS RESISTANT TO CYTOTOXICITY 
OF 5 mM 3-ACETAMIDOBENZAMIDE (3-AAB)
Mutant L1210 cells were selected in a stringent system by the ability to form 
colonies in soft agar containing 5 mM 3-AAB. About 1.0-1.5xl06 cells were seeded 
in 8-10 ml agar medium in 6 cm petri dishes. For each set of isolation experiment 
about 20 (or more) petri dishes were prepared. These petri dishes were incubated 
for at least 4 weeks at 37 deg.C in a humidified atmosphere of 5% (v /v ) C 02/a ir 
(see chapter 4 section 4.1.4). 5 mM 3-AAB was present in agar medium throughout 
the incubation time.
Mutation frequencies are expressed as per 107 viable cells plated. Calculated from 
the equation below.
_________ No of m utants_________
No of cells seeded x Cloning efficiency
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3.4.2 THE PROCESS OF FREEZING MUTANT CELL LINES IN LIQUID 
NITROGEN
M utant cells were grown in media containing 5 mM 3-acetamide- benzamide 
(selective medium) to obtain a large population of cells (about 250-300 ml). Cells 
were collected during late logarithmic growth curves (early stationary phase). This 
was done by using a sterile pasteur pipette to remove the supernatant media, 
leaving the layer of cells on the bottom undisturbed. The supernatant media was 
removed so that a high density of cells (2xl06 cells/m l) was achieved. The bottles 
of the cells were then placed on ice 5 min prior to adding 1 ml of DMSO for every 10 
ml of cells. Aliquots of 2 ml of cells were dispensed into sterile tubes. The tubes 
were cooled slowly over liquid nitrogen in a special container overnight. The 
process of slow cooling could also be achieved by insulating the tubes with 
polystyrene (2 inches thick) then placing them at -70 deg.C overnight. The 
following day. all the tubes were placed in liquid nitrogen storage.
3.4.3 THE PROCESS OF GROWING MUTANT CELLS FROM LIQUID 
NITROGEN STORAGE
M utant cell lines stored in liquid nitrogen, were thawed at 37 deg.C inawater bath 
and suspended in complete RPMI growth medium to a cell density of 2xl05 
cells/ml. After 18 h cells were collected by centrifugation (1000 rpm for 5 min) 
using a bench centrifuge and selective medium was added. This procedure was 
adopted so that DMSO was removed and m utant cells were maintained in selective 
medium as stock cells ready to be prepared for various experiments. A stock of 
m utant cells were checked periodically and routinely subcultured to 5x l04 cells/ml 
when they reached the stationary phase. The stock of m utant cells were replaced
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after 3 months by thawing another tube of cells obtained from liquid nitrogen 
storage.
3.4.4 PREPARATION OF MUTANT CELLS FOR VARIOUS EXPERIMENTS
M utant cell lines were prepared for various experiments from a stock of cells (from 
m utant cells kept in medium containing 5 mM 3-AAB). by washing the cells 4 
times with 15 ml of warm normal RPMI growth medium. This washing was to 
ensure that 3- AAB was removed. After washing, m utant cells were grown in 
normal RPMI medium and were subcultured at 5xl04 cells/ml ready for various 
experiments. All m utant cells grown in medium free of 3-AAB were used for 10 
days then discarded. Mutant cells were always used during mid-log phase for all 
experiments.
3.4.5 ESTIMATION OF SURVIVAL OF L1210 AND MUTANT CELL LINES IN 
AGAR CONTAINING VARIOUS CONCENTRATIONS OF 3-AAB
An aliquot of 20 jul (100 cells) from the final dilution was plated on each petri dish 
with 8 ml of complete RPMI 1640 medium supplemented with 0.3% agar and the 
chosen concentration of 3- AAB was present in the agar medium throughout the 
incubation time. A high number of cells (>100 cells) were plated if the 
concentration chosen was too toxic to allow less than 1% of cells to survive. Five 
petri dishes were prepared for each treatment group and they were incubated for 
10-14 days for wild- type cells and 22-27 days for m utant cells.
For those treatment groups requiring pretreatment with 50 juM dimethylsulphate 
(DMS) for 1 h. 3-AAB (0.5 mM) was added to cells at least 10 min prior to the
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addition of DMS. 3-AAB was present throughout the dilution procedure and during 
the incubation time. The washing procedure was regarded as unnecessary due to the 
high cell density (106 cells/ml) used and the subsequent small aliquot (about 5xl04 
cells) of cell suspension required for the serial dilutions. Furthermore, the half-life 
of DMS is short (about 10-15 min) thus the amount of residual DMS was considered 
to be negligible.
3.5 CELL VIABILITY
Cell viability was determined using 0.2% trypan blue in saline, an equal volume of 
medium was usually added. The cells were examined under the microscope. Dead 
cells or permeable cells (permeabilised cells) were stained blue, while viable cells 
remained unstained.
3.6 PREPARATION OF INHIBITORS AND DMS
Stock solutions of 3-acetamidobenzamide and 3-nitrobenzamide at concentrations 
above 10 mM (left at room temperature) were heated to ensure complete 
solubilization; up to 24 mM they were in solution at 37 deg.C. Both inhibitors are 
very stable when heated, hence stock solutions were prepared by dissolving in 
double glass distilled water and sterilized by autoclaving at 15 lb/in for 20 min.
3-Aminobenzamide is readily soluble in warm double glass distilled water up to 100 
mM. Stock solutions were sterilized using a microflow filter, pore size 0.22 u and 
stored at 4 deg.C.
The three acid analogues (3-acetamidobenzoic acid. 3- nitrobenzoic acid and 3-
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aminobenzoic acid) are insoluble in water, thus sodium hydroxide was added and 
the solution adjusted to pH 7.4. Stock solutions were prepared and filter- sterilized 
using a microflow filter.
DMS is a liquid at room temperature and does not require sterilization. Solution of 
DMS in absolute ethanol was prepared immediately before use.
3.7 SCINTILLATION COUNTING
All radioactive samples were counted in Packard Tri-Carb liquid scintillation 
spectrometer. Optiphase was used as scintillant; for most non-aqueous samples, 3 
ml of optiphase solution was used but for aqueous samples, 9 parts of optiphase 
was used for every 1 part of aqueous sample.
3.8 MEASUREMENT OF ACID INSOLUBLE RADIOACTIVITY
Acid-insoluble radioactivity was measured by applying the reaction mixture (up to 
25 pi) to whatman 2.4 cm filter paper discs (presoaked in 20% (w /v) TCA in 
diethylether for 15 min). The discs were washed four times in 400 ml of ice cold 5% 
TCA (w /v) for 15 min each and once in 95% ethanol. After drying, the 
radioactivity was counted. Counting efficiency was 85-90% for [14C] and 55-60% 
for [3H].
3.9 THIN LAYER CHROMATOGRAPHY (t.l.c)
Thin layer chromatography was performed using PEI cellulose. Before use, it was 
first soaked in 2M NaCl for 30 min and then in distilled water for at least 30 min
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and left to dry at room temperature. Standard NAD was made up in 50% ethenol 
at a final concentration of 5-10 mg/ml. Samples (about 20 ;ul) were applied to the 
origin (2 cm from the bottom of the plate) using capillary tubes and dried under a 
stream of cold air. The spots on the t.l.c. plate were left to develop in a butanol 
system for 3-5 h. In this system, Butanol: Water: Methanol: Ammonia in the ratio 
60:20:20:1 was used to achieve a good separation of nicotinamide (RF=0.71) and the 
pyridine nucleotides NAD, NADH and NADP (RF=0) which remained at the origin. 
A fter developing, the plates were then visualized under an ultraviolet (UV) light 
w ith emission at 250-280 nm . For radioactive counting, the sheet was divided into 1 
cm strips, 1 ml of 0.5 M percholic acid was added and incubated in scintillation 
vials at 90 deg.C for 30 min. This procedure hydrolyses and solubilises the 
radioactive adenine group from the rest of the nucleoside/nucleotide. Samples were 
left to cool and then counted.
3.10 CELL PERMEABILIZATION
The cell permeabilisation method was essentially that of Durkacz et al (1980a). 
Cells were chilled to 4 deg.C and centrifuged in the cold for 5 min at 1500 rpm 
using MSE bench centrifuge. They were washed once with ice-cold Puck's saline 
(containing 400 mg/1 KH2P04 , 350 mg/1 NaHC03, 8 mg/1 NaCl and 1 g/1 glucose at 
pH 7.4). The pellet was resuspended in cold hypotonic buffer (containing 9 mM 
HEPES, 4.5% (w /v) dextran. 1 mM EGTA, 4.5 mM MgCl2, 5 mM DTT at pH 7.8) to 
a final density of 3-5xl07 cells/ml and were left at 4 deg.C for 50 min. Finally, this 
concentrated cell suspension was diluted 10 times by the addition of cold isotonic 
buffer (containing 40 mM HEPES, 130 mM KC1, 4% (w /v) dextran, 225 mM 
sucrose, 2 mM EGTA, 2.3 mM MgCl2 and 2.5 mM DTT). The efficiency of 
permeabilization was determined by trypan blue exclusion.
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3.11 TRANSPORATION OF 3-ACETAMIDOBENZAMIDE (3-AAB) INTO THE 
CELLS
g
Cultures of wild-type L1210 and m utant cells (3 ml) at 5x10 cells/ml were 
incubated with 15 ;ul of [3H] 3-AAB (117 nCi/ml). At various times, .200 jul 
sample (lxlO6 cells) were filtered on to Millipore GFC disc (prewashed w ith 3 ml 
ice cold PBS). The discs were then washed with 3x10 ml of cold PBS, dried at room 
temperature and the radioactivity counted.
3.12 DNA ESTIMATION
The Burton assay was used for measuring DNA; it is a colorimetric procedure for 
measuring the deoxyribose moiety of DNA (Burton, 1956). The procedure was 
divided into 2 steps. For the first step; whole cells containing lipids (2xl06 cells) 
were washed, first with 0.2 M PCA in 50% ethanol and 50% distilled water, mixed 
well and left on ice for 15 min. The cell pellet was collected by centrifugation for 5 
min at 1500 rpm using an MSE bench centrifuge. It was then washed w ith 1 ml of 
ethanol-ether (3:1, v /v ), left for 10 min at 70 deg.C then centrifuged as above. 
Finally, the pellet was mixed with 1 ml of 95% ethanol, vortexed and centrifuged to 
discard the supertanant.
Second step: The pellet was treated with 1 ml of 0.5 M PCA and hydrolyzed for 70 
min at 70 deg.C, cooled on ice, centrifuged and the supernatants were collected into 
marked tubes. For every 1 volume of supernatant added, 2 volumes of 
diphenylamine reagent. It was prepared using 1.5 g of diphenylamine in 100 ml 
glacial acetic acid and 1.5 ml of (98-100%) H2S04, just before used 0.5 ml of 
acetaldehyde stock solution (2 ml of acetaldehyde in 100 ml distilled w ater) was
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added to it. The solution was mixed and incubated at 30 deg.C for 18 h. The 
absorbances at 595 and 650 nm, using 0 tig/ml standard as a blank, were read from 
the spectrophotometer. The unknown DNA concentrations of the cells were read off 
from  the standard curve of known DNA concentration.
For the standard curve of known DNA concentrations, 0.5 ml DNA stock solutions 
(8.5, 17, 42.5, 85 and 170 tig) in 1 ml of distilled water was mixed with 0.5 ml of 1 
M PCA, then assayed according to the step two above. A standard curve was 
obtained by plotting the absorbance at 595 nm minus absorbance at 650 nm as a 
function of the initial DNA concentration.
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CHAPTER 4
ISOLATION OF MUTANT L1210 CELLS RESISTANT TO 5 mM
3-ACETAMIDOBENZAMIDE AND THEIR CHARACTERIZATIONS
CHAPTER 4
4.1 PROCEDURE FOR THE ISOLATION OF MUTANT CELLS RESISTANT TO 
AN INHIBITOR OF ADPR TRANSFERASE
4.1.1 Cell line
Meuse lymphoma L1210 cells were used for this investigation as they have been 
routinely used in this laboratory for the study of various aspects of ADP- 
ribosylation. This cell line has been adopted to grow in culture and it has 
characteristics that are of general interest to investigators. The cells grow quickly 
w ith a generation time of approximately 12-13 h and they are easy to handle as they 
grow in suspension culture. The cells do not adhere to the culture vessel and they 
only associate loosely with each other. This is an advantage as the cells do not need 
to be trypsinized. This has greatly simplified maintenance of cultures and the 
measurement of cell number and growth rate.
L1210 cells can form single - cell derived colonies when immobilized in medium 
made semisolid with agar. This property is defined as plating efficiency. It 
measures the number of colonies of cells (each colony being derived from one cell) 
that form from dilute concentrations of cells plated in agar medium (usually 100- 
200 cells). This is calculated as:
No of colonies isolated x 100 
No of cells seeded
The plating efficiency for L1210 cells determined in this laboratory is 72±4.9% (50
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determinations). This high plating efficiency has proven invaluable in quantitating 
the effect of drugs on cell viability in the isolation of drug-resistant mutants. In 
many established cell cultures (and most primary cell cultures) the plating 
efficiency is too low. It is often less than 1% or as low as 0.001% (Ham, 1964; 1965). 
It was found that in the development of cloning techniques cells leak nutrient into 
the medium and secrete chemical messengers that are required for survival and 
growth (Samford et al., 1963; Ham, 1963b) hence, some cell lines do not give a good 
plating efficiency.
4.1.2 Inhibitor o f ADPR transferase used
3-Acetamidobenzamide (3-AAB) was chosen as it has been shown to be the most 
potent of the ADPR transferase inhibitors causing 98% inhibition of the enzyme 
from calf thym us at 1 mM. Moreover, 3-AAB is 6-8 times more effective as ADPR 
transferase than is 3-aminobenzamide (Purnell and Whish, 1980).
4.1.3 Dose o f inhibitor
A suitable concentration of inhibitor was chosen for m utant selection. It was
s
suggested by Rabin and Gott&nan (1979) that the 2 x concentration of drug which 
allows survival of 10% of the original population (LD10) is a suitable concentration 
for selection purposes. It was found that the killing of the original population was 
substantial at such  concentration.
The dose response of w ild-type cells to a potential selective inhibitor could be 
measured either in terms of growth rate or plating efficiency in the presence of 
inhibitor. Plating efficiency is preferable because it permits an evaluation of
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population heterogeneity throughout the dose range and is also a more sensitive 
indicator of the minimum dose necessary to kill the w ild-type cells and to discern 
any unusually resistant clones. The percentage survival of L1210 cells in various 
concentrations of 3-acetamidobenzamide (3-AAB) is determined in agar medium 
and is shown in figure 5. It is expressed as percentage survival of the control, 
calculated from equation below.
No of cells grown into colonies in 3-AAB x 100 
No of cells grown into colonies in the absence of 3-AAB
The concentration of 3-AAB which allows 10% of cells to survive is about 2.5 mM.
The concentration of 5 mM (2 x 2.5 mM) 3-AAB was therefore chosen to isolate the
m utant cells resistant to 3-AAB.
4.1.4 Methodology o f developments for the isolation o f m utant cells during 
the long incubation period in C 02/a ir
A large population of wild-type cells were exposed to 5 mM 3- acetamidobenzamide 
in agar medium for the period of at least 4 weeks. This period was considered to be 
quite long compared to only 10-14 days for a normal single cell which grows into a 
colony in a normal agar medium RPMI 1640. When this work was initiated two 
major problems threatened the opportunity of obtaining m utant cells. The biggest 
problem was the medium evaporating during the long incubation period. 
Even though cells in petri dishes were maintained in a humidified C 02/air incubator, 
the humidity generated in the incubator was not sufficient to prevent drying of the 
agar medium . It was observed that the agar medium was reduced to 3/4 of its 
original volume by the end of the th ird  week. This means that populations of cells
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Diluted cells (100 or more) were plated on to 6 cm petri dish containing various 
concentrations of 3-AAB. After 3 weeks colonies were counted and calculated as 
percentage survival from equation below (5 petri dishes per each data point).
No of colonies in the presence of 3-AAB x 100 
No of colonies in the absence of 3-AAB
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were exposed to the increasing concentrations of 3-AAB, which is so toxic tha t it 
w ill not permit even the m utant cells to develop into colonies. The second problem 
was the mycoplasma or fungal contamination found in the environment, which 
affected the cloning procedures.
A method was therefore developed to circumvent medium evaporation and to 
minimize the risk of contamination. A square plastic box, easily obtainable from 
any supermarket store, of 25 (length) x 8 (height) cm was used as mini incubator 
when placed inside the C 02/a ir incubator. Four holes of about 2.5 cm in diameter 
were made at each side of the square box. The holes were sealed w ith kitchen cling 
film, to act as a permeable membrane for C02.
Cells grown in suspension or agar medium, inside the box with the lid closed tight, 
have been found to behave as cells grown outside the box (w ith the same generation 
times). This demonstrated that C 02 in the incubator is passing through the cling 
film into the box. Sterile w ater was placed at the bottom of the box to provide 
hum idity which prevents the agar medium from becoming dry  during the 
incubation period. It was observed that medium evaparation had not occured even 
at the end of 2-3 months. Washing the inside of the box with 75% ethanol before 
use, with the lid closed very tightly, helped to minimize contamination. Another 
advantage with using these boxes is that it has reduced space shortage inside the 
C 02/air incubator as boxes can be placed on top of one another. This allows large 
experiments involving the use of many petri dishes to be performed. Plastic boxes 
made for the purpose of isolation m utant cells are still being used in this laboratory 
to grow various cell lines for various experiments.
4.1.5 Cloning mutant cells resistant to 5 mM 3- acetamidobenzamide (3-AAB)
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W ild-type L1210 cells were grown in suspension medium in glass tissue culture 
bottles. For routine subculturing, cells were counted using a haemocytometer to 
estimate cell numbers. This provided a visual check on the state of the cells. Cells 
used were always in mid-log phase (5-7 x 105 cells/m l) as most of them were 
healthy and active. Cells were collected by centrifugation and about 1.00-1.5 x 106 
cells were plated in 6 cm petri dish containing 8-10 mlQ3% agar medium 
supplemented with 5 mM 3-AAB. Once all cells were plated on to petri dishes, 
which were varied according to total cells used (for example 10 petri dishes for 10 x 
106 cells), they were put inside the plastic boxes and placed in C 02 incubator.
It is sometimes necessary to treat cells w ith a mutagen in order to obtain m utants in 
significant numbers (Kao and Puck, 1967). In this investigation mutagens (eg DMS, 
MNNG) were not used as ADPR transferase activity is stimulated by such agents 
(see chapter 1 section 1.1.9). Such procedures might interfere w ith the isolation of 
m utants which are potentially ADPR transferase deficient.
Cloning m utant cells in soft agar plating allows the individual cells which are 
resistant to the cytotoxic effect of 3-AAB to divide and form colonies large enough 
to be seen by the naked eye. The normal soft agar plating of L1210 cells produces 
colonies of 1 or 2 mm in diameter within 10-14 days, but m utant cells treated w ith 5 
mM 3-AAB required at least 4 weeks before the colonies had grown enough to be 
picked and maintained in suspension culture in the presence of 5 mM 3-AAB. This 
selective pressure was constantly present in the population of m utant cells to 
prevent them being overgrown by revertant cells during continuous subculture.
The total number of cells used for various cloning procedures is shown in table 4. 
It also shows the number of colonies obtained in each cloning assay. Some colonies
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failed to proliferate in suspension medium. W ithout further investigation, it is not 
easy to explain the reasons for such phenomena. M utant frequency per survival is 
calculated from the equation below.
Total colonies observed in 5 mM 3-AAB_____________
Total number of cells plated in 5 mM 3-AAB x Plating efficiency
Out of 22 colonies which had proliferated in suspension medium only 12 clones 
were investigated. This is because each m utant requires a good deal of time for its 
investigation. It was considered that 12 m utants were sufficient for a preliminary 
investigation.
The 12 mutant clones were re-cloned again in the agar medium containing 5 mM 3- 
AAB. The re-cloning was to ensure separation of cells which may have clumped 
together at the time of the first cloning (a colony which did not arise from a single 
cell). This procedure ensured that each m utant clone tested was derived from single 
cell.
4.1.6 Re-cloning o f mutant cells in soft agar plating
M utant cell lines have been established in suspension medium in the presence of 5 
mM 3-AAB and have been subcultured 2- 3 times. The sub-culturing was done 
every 3-4 days at 5xl04 cell/ml. M utant cells were diluted and 100 cells were 
plated in soft agar containing 5 mM 3-AAB. A fter a period of 4 weeks, 1 colony 
from each m utant cell line was picked and recloned again for the third time. The 2 
consecutive clonings were performed so that their resistance to 3-AAB could be 
tested in terms of plating efficiency in agar cloning assay. Results obtained for the 2
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consecutive cloning assays are shown in table 5.
DISCUSSION
The apparent mutation frequency per survival of L1210 cells, which result in 
resistance to 5 mM 3-AAB is in the range of 1- 3 x 10"7 . Other spontaneous 
mutation frequencies are in the range of 10“5 -10"11 (see chapter 1 section 2.3 and 
2.4).
Plating efficiency of m utant cells for the first re-cloning is quite low (see table 5). 
Colonies obtained from 100 cells plated are in the range of 5-30 colonies. A higher 
number of colonies were obtained from the second re-cloning in which 50 colonies 
or more per petri dish was achieved. This suggests that when m utant cells were 
maintained under selective pressure, a progression to higher level of resistance 
occurs.
Low plating efficiency from the first re-cloning suggests that some m utant cells 
from various lines are unstable. This phenomenon was recognized earlier ( Nature 
(London), New Biol 237, 98 (1972) ).
- 7 0 -
TABLE 4 Clones of mutant L1210 cells resistant to 5 mM 3- acetamidobenzamide (3-AAB)
Number Total No of Mutation No of
of cells colonies frequency colonies
cloning in each isolated per grown in
assays assay per survival suspension
x 107 assay per 10'7 medium
cells 5 mM 3-AAB
1 2.2 2 1.28 2
2 2.7 4 2.10 4
3 4.7 4 1.20 2
4 5.2 12 3.29 3
5 6.5 9 2.00 4
6 4.5 3 0.95 3
7 10.0 11 1.57 1
8 6.2 9 2.07 1
9 6.7 11 2.34 2
Total 48.7 65 22
A large population of wild-type L1210 cells (about lxlO 6 cells) were plated onto 6 
cm petri dish, containing agar medium, supplemented with 5 mM 3-AAB (See 
chapter 3.4.1). The number of m utant clones obtained in each stage of cloning 
assay, mutation frequency and number of m utant clones which survived in 
suspension medium in the presence of 5 mM 3-AAB are listed.
TABLE 5 Re-cloning of mutant cell lines in 5 mM 3 - aceiamidobenzamide (3-AAB)
M utant First re-cloning Second re-cloning
cell line number of colonies number of colonies
number from 100 cells from 100 cells
plated (5 results plated (5 results
per data point) per data point)
3 9.0 ± 3.0 78.8 ± 2.0
4 10.0 ± 0.5 60.3 ± 5.7
5 11.0± 1.7 70.3 ± 4.3
6 16.3 ±2.8 72.6 ± 2.9
7 32.0 ± 1.7 75.1 ± 1.4
9 11.3 ± 3.1 54.0 ± 5.2
10 10.6 ± 1.5 79.0 ± 3.6
12 12.5 ±5 .0 90.3 ± 9.0
13 26.0 ±3.8 89.3 ± 13.0
14 33.0 ± 2.0 76.0 ± 3.6
15 16.4 ± 4.0 31.8 ± 1.0
16 5.3 ± 1.2 30.0 ± 2.5
M utant cell lines isolated from wild-type cells (see 4.1.5) grown in suspension 
medium containing 5 mM 3-AAB were diluted and plated on to 6 cm petri dish. 
After 4 weeks, mutant colonies picked from 1st re-cloning were re-cloned as before 
(see 4.1.6).
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4.2 CHARACTERIZATIONS OF MUTANT CELL LINES
One of the clones from the second re-cloning was isolated for each m utant cell line 
then regrown in suspension medium containing 5 mM 3-AAB. The following 
characters were analysed and compared with their w ild-type L1210 cells.
4.2.1 Growth rates o f mutant cell lines in the presence and absence of 
selective pressure (5 mM 3-AAB)
To determine the growth rates. 5 ml of wild-type and m utant cell lines were 
suspended in culture medium at 5 x 104 cells/ml to determine cell density (cells/ml) 
over a period of 98 h. At time intervals of 12 h. cell density was determined w ith a 
haemocytometer using a Zeiss binocular microscope. Results were summarized and 
presented in tables 6 (a&b) and 7.
DISCUSSION
Figure 7 shows the growth curves of m utant 3 and w ild-type cell lines in the 
absence and presence of 5 mM 3-AAB. Growth curves of other m utant cell lines are 
not shown as they are similar. The doubling times and maximum cell densities at 
the stationary phase are summarized in table 6 a. b. Table 7 shows the ratio of 
doubling time of wild-type to m utant cell lines and the ratio of the doubling times 
of mutants, within the same cell line, in the presence and absence of 5 mM 3-AAB.
When selective pressure is absent, w ild-type cells started to enter early stationary 
phase at about 1 x 106 cells/ml whereas m utant cells start to enter early stationary 
phase at about 3- 4.5 x 105 cells/m l. (See table 6a). Furthermore, wild-type cells
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TABLE 6 a. Comparison of the doubling time of w ild-type and 
m utant cell lines grown in RPMI 1640 medium (no 
3-AAB) and the maximum cell density (cells/m l) at 
stationary phase, (see also figure 6 a&b)
Cell lines Doubling time Maximum cell Number of 
(h) density (cells/ml) experiments
Wild-type 12 ± 2 100 ± 12 10
Mutant 3 29 ± 1 41 ± 7 9
4 23 ± 1 38 ± 6 6
5 24 ± 2 37 ± 3 6
6 29 ± 3 32 ± 6 6
7 20 ± 1 46 ± 5 6
9 23 ± 1 37 ± 2 6
10 24 ± 2 40 ± 4 6
12 26 ± 2 41 ± 5 6
13 20 ± 1 38 ± 5 6
14 24 ± 2 34 ± 3 6
15 20 ± 2 33 ± 4 6
16 22 ± 2 35 ± 3 6
Cells (at 5x104 cells/ml) were grown in RPMI 1640 medium over period of 96 h. at 
time intervals of 12 h the cell density was determined. Cell cycle doubling times 
were determined from slopes of growth curves, calculated from least square 
regression analysis of the data.
TABLE 6 b. Comparison of doubling time of w ild-type and mutant 
cell lines grown in RPMI 1640 medium containing 
5mM 3-AAB and the maximum cell density (cells/ml) 
at stationary phase (see also figure 6 a & b )
Cell lines Doubling time Maximum cell Number of 
(h) density (cells/ml) experiments
Wild-type 0 N.P. 3
Mutant 3 32 ± 2 35 ± 8 9
4 30 ± 2 39 + 3 8
5 28 ± 3 38 ± 2 6
6 36 ± 2 28 ± 2 6
7 31 + 2 32 ± 5 8
9 35 ± 2 29 ± 3 6
10 29 ± 2 34 ± 4 6
12 37 ± 3 40 ± 6 6
13 37 ± 3 27 ± 1 6
14 27 ± 3 25 ± 3 5
15 43 ± 2 26 ± 1 5
16 45 ± 4 27 ± 2 6
N.P. = Non-proliferative
Cells (at 5x 104cells/ml) were grown in RPMI 1640 medium containing 5 mM 3- 
AAB over period of 96 h. At time intervals of 12 h the cell density was 
determined. Cell cycle doubling times were determined from slopes of growth 
curves, calculated from least square regression analysis of data.
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TABLE 7 (A) Ratios of doubling time of wild-type (W.T.) 
to mutant cells (M.T.) [W.T. : M.T.]
(B) Ratios of doubling time of each m utant cell 
line in the absense of 5 mM 3-acetamidobenzamide 
(-AAB) to its doubling time in the presence of 5
mM 3-acetamidobenzamide (+AAB) [M.T. (-AAB) : M.T. (+AAB)]
M utant (A) (B)
number
3 1 : 2.4 1 : 1.10
4 1 : 1.9 1 : 1.30
5 1 : 2.0 1 : 1.17
6 1 : 2.4 1 : 1.24
7 1 : 1.7 1 :: 1,55
9 1 : 1.9 ■1 : 1.52
10 1 : 2.0 1 : 1.21
12 1 : 2.2 1 : 1.42
13 1 : 1.7 1 : 1.85
14 1 : 2.0 1 : 1.13
15 1 : 1.7 1 : 2.15











FIGURE 6.a Comparison of the doubling time of w ild-type 
and m utant cell lines in the presence and 
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FIGURE 6.b Comparison of the maximum cell density of wild 
type and m utant cell lines at stationary phase 
in the presence and absence of 5 mM 3-AAB 
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FIGURE 7 Growth curves of wild-type and m utant 3 cells in 
the presence and absence of 5mM 3-AAB (as 
described in table 6 a & b).
wild-type
1 x 1 0 -
m utant 3
1 x 1 0 -
0  3 0  6 0  9 0  1 2 0
Time (min)
■ = in the absence of 3-AAB ; ▲ =in the presence of 3-AAB
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Figure 8 Picture of mutant 3 and wild-type cells
MUTANT 3 CELLS
WILD-TYPE CETJ.S
Diameter of mutant and wild-type c e lls  using magiscan 2A 
(from 100 c e l l s ) :  Diameter of mutant 3 c e lls  = (1.611*1.8)xl0 urn
Diameter of wild-type c e lls  = (1.214±0.117)xl0 pm
The ra t io  of diameter mutant: wild-type = 1:1.32
have a shorter doubling time of 12-13 h but they do not proliferate in 5 mM 3-AAB. 
It is evident that m utant cell lines have longer doubling times which are in the 
range of 20- 30 h and the maximum cell density of m utant cell lines are 2-3 fold 
less than wild-type cell density at the stationary phase (see figure 6a. b). The sizes 
of m utant cells are larger than w ild-type cells (figure 8), and when viewed 
subjectively by the naked eye they were estimated to be one and a half times larger. 
As all the m utant cell lines have been shown (from microscope examination) to be 
of similar size, only the size of m utant 3 and wild-type cell lines were measured 
using a magiscan 2A machine (Joyce Loebl). This machine magnifies the sizes of 
cells and projects them on a screen which automatically reads off the diameter scale 
and prints it on the screen. The mean value of cell diameter of m utant 3 (from 100 
cells sample) is 1.32 times larger than the average diameter of w ild-type cells (see 
figure 8). The difference in cell density at the early stionary phase of wild-type and 
m utant cell lines may be due to the depletion of chemical substances in the medium, 
as bigger cells would have taken up more substances from the medium in order to 
synthesize various cellular components e.g. additional molecules of protein, nucleic 
acid, carbohydrates, lipids and other cellular constituents before cell division.
As seen from table 7 and figure 6(a), all m utant cell lines have a longer doubling 
time in the order of 1.6-2.3 times longer compared to wild-type cells. Results also 
show that the doubling times of m utant cell lines under selective pressure are 
longer than the doubling times obtained in the absence of selective pressure (figure
6.a). For mutants 13, 15 and 16. the doubling time is twice as long and for mutants
7, 9 and 12 the increase factor is about 1.5. The doubling time of other mutants is 
about 1.1-1.3 longer in the presence of 5 mM 3-AAB. It is interesting that m utant 3 
has almost the same doubling time in the presence and absence of 5 mM 3-AAB. 
This shows that the inhibitor has very little effect on cell growth in this mutant.
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The characteristics of the doubling times of mutantcell lines isolated with 5 mM 3- 
AAB are different compared to mutant cell lines obtained by other workers. 
M utants of HeLa cells, selected in the presence of 10 mM 5-methylnicotinamide 
(Kidwell and Burdette 1974) and of L1210 cells isolated in the presence of 6 mM 5- 
methylnicotinamide (Nduka and Shall, 1980) have been shown to grow with 
similar doubling time to their wild-type in the absence of their selective pressure. 
The doubling time of 24 and 12 h were observed for the m utant and its wild-type of 
HeLa cells and for the m utant and its wild-type of L1210 cells respectively. The 
same result was also observed in variant L1210 isolated in the presence of 3- 
aminobenzamide after the cells were mutagenised by DMS (M urray et al., 1986). 
Moreover, variant cells L25A isolated in the gradually increasing concentration of 
3-aminobenzamide have a doubling time of 15 h compared to 12 h for its wild-type.
The difference in the length of cell cycle of mutant cell lines in the presence and 
absence of 5 mM 3-AAB (see figure 6.a) may be due to one of the cell cycle phases 
which contribute to the difference of cell cycle length observed. There is a generally 
accepted view that the variation of doubling time among different cell types is 
mainly due to the length of Gj (Killander and Zetterberg, 1965; Worthington et al., 
1976), although in certain systems, e.g. m utant of Tetrahymena thermophila (Schafer 
and Cleffmann, 1982), it has been shown that the variation in cell cycle times of a 
m utant and its w ild-type is due to G j, S and G2.
3-Acetamidobenzamide (3-AAB) may affect G2 phase in cell cycle of m utant cell 
lines. This effect is concluded from reports obtained from using other inhibitors. 
For example variant L25A cells which are resistant to 25 mM 3-aminobenzamide 
were shown to have a slightly higher fraction of G2 cells. (Tavassoli et al., 1987a). 
3-Methoxybenzamide was found to cause a large accumulation in G2 such that the
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first completion of mitosis was at 38 h instead of 26-28 h in untreated C3H10 T l/2  
cells (Jacobson et al., 1985a). Another report shows that using 5 mM 5- 
methylnicotinamide affects the G2 of m utants of HeLa cells (resistant to 5mM 5- 
methylnicotinamide) (Kidwell and Burdette, 1974). 3-AAB may also affect Gj 
phase as well as G2. This conclusion is based on the report that 3-AAB effects
growth arrest in Gj and G2 of HeLa cells (Kidwell et al., 1985).
In response to selective pressure, m utant cell lines may enter into sub optimal 
growth conditions by entering the Go state as it was shown that various drugs cause 
cells to enter Go state (Pardee and James. 1975). Furthermore, a certain percentage 
of m utant cells in various cell lines may not undergo the process of cell division; 
instead, they may remain in Go state and this eventually results in cell death. To 
verify these observations, the sensitivity of m utant cell lines to various doses of 3- 
AAB was investigated in the next section.
4.2.2 C ytotoxicity of 3-acetamidobenzamide (3-AAB) to mutant cell lines
Cell survival in soft agar is used to measure the effect of 3- AAB on m utant cell 
lines. For each treatment, a group of 100 cells for each m utant cell line was plated 
on to a petri dish with no inhibitor (control), 1, 3, 4, 5, and 6 mM 3-AAB and 500 
cells for 7 mM 3-AAB. Five petri dishes were prepared for each independent 
experiment. A fter 4 weeks of incubation at 37 deg.C and 5% C 02, inside the plastic 
box (as described in 4.1.4), colonies were counted from each treatment group and 
calculated as percentage survival from the equation below.
No of colonies in the presence of 3 AAB (+) x 100 %
No of colonies in the absence of 3 AAB (-)
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The plating efficiency of m utant and wild-type cell lines which had received no 3- 
AAB is in the range of 40-70% (30 determinations for each m utant cell line) and 
72±4.9% for w ild-type cells (50 determinations). The percentage survival of 
m utant cell lines and wild-type cells after treatment with various concentrations of 
3-AAB is plotted as a semi log plot in order that a direct comparison be made [see 
figure 9 (a-d)]. Table 8 shows the percentage survival of m utant cell lines in the 
presence of 5 mM 3-AAB and table 9 shows the concentration of 3-AAB which 
allows 10% of m utant and wild-type cell lines to survive.
DISCUSSION
The percentage survival of m utant cell lines obtained in 5 mM 3-AAB is shown in 
table 8. The mean value of percentage survival obtained from 3 independent 
experiments (5 petri dishes per each independent experiment) for most m utant cell 
lines, in 5 mM 3-AAB, is above 50% except m utant 16 which is 35%. A 50% 
survival for w ild-type was achieved at 1.5 mM (figure 9.a) showing that a 3 fold 
increase in 3-AAB concentration for m utant cell lines was needed to achieve a 
similar effect. Concentrations of 3-AAB [extracted from figure 9 (a-d)] which 
allowed 10% cell survival in w ild-type and m utant cell lines and their ratio are 
summarized in table 9 and presented as graph in figure 10. Results show that the 
concentration of 3-AAB which allows 10% of m utant cells to survive is increased by 
a factor of 2.5-3.0 (compared to w ild-type), with a slightly higher factor of 3.4 for 
m utant 13.
Results from table 8 and 9 clearly demonstrate that m utant cell lines are more 
resistant to the cytotoxicity of 3-AAB. Higher doses were needed for mutant cell
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TABLE 8 Percentage (%) survival of mutant cell lines treated
continuously with 5 mM 3-AAB in agar plating. Each 
data point was calculated from 5 separate experiments.
Cell lines 1st 2nd 3rd Mean
expt expt expt value
% % %
M utant 3 41 ± 10 78 i 9 35 ± 8 51
4 52 ± 10 80 ± 10 42 i 6 57
5 61 ± 4 80 ± 6 45 i 7 62
6 38 ± 4 55 ± 7 80 ± 8 57
7 62 ± 7 30 ± 7 62 ± 9 52
9 49 ± 7 52 ± 7 83 ± 10 61
10 59 ± 7 45 ± 6 90 ± 8 65
12 53 ± 5 45 ± 5 82 + 7 60
13 70 ± 10 79 ± 8 60 ± 5 69
14 69 ± 9 47 ± 9 87 ± 7 67
15 40 ± 8 52 ± 8 75 ± 10 55
16 28 ± 3 44 ± 4 35 ± 4 35
M utant cells of various cell lines were diluted and plated (100 cells) onto 6 cm 
petri dish in media containing 5 mM 3- AAB. After 4 weeks, colonies were counted 
and calculated as percentage survival according to the equation below:
No of colonies in the presence of 5 mM 3-AAB x 100%
No of colonies in the absence of 5 mM 3-AAB
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TABLE 9 (A) = Various concentrations (mM) of 3 acetamidobenzamide 
(3-AAB) which allow 10% of m utant and wild-type cell lines 
to survive in the continuous treatment of 3-AAB in agar 
plating (extracted from figure 9 a. b, c, d).
(B) = Ratio of 3-AAB (mM) concentrations (shown in colum A) 
which allow 10% survival of mutant cells to wild-type cells.
As a:b
a) 3-AAB (mM) giving 10% survival of m utant cells
b) 3-AAB (mM) giving 10% survival of wild-type cells
Cell lines (A) (B)
W ild-type 2.5 -

































FIGURE 9.a Cytotoxicity of 3-AAB on wild-type and mutants
3,4,5 cell lines treated continuously in soft
agar (see "Methods" chapter 3.4.5). (5 experiments per each data point).
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FIGURE 9.b Cytotoxicity of 3-AAB on mutants 6,7.9 cell
lines treated continuously in soft agar (see
"Methods" chapter 3.4.5). (5 experiments per each data point).
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m utant 61 0 - ■
1 0 0
m utant 71 0 -
100
m utant 9
1 0 - -
0 4 6 82
3-AAB Concentration (mM)
- 88 -
FIGURE 9.c Cytotoxicity of 3-AAB on mutants 10,12,13 cell
lines treated continuously in soft agar (see
"Methods" chapter 3.4.5). (5 experiments per each data point)
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FIGURE 9.d Cytotoxicity of 3-AAB on mutants 14,15,16 cell
lines treated continuously in soft agar (see
"Methods" chapter 3.4.5). (5 experiments per each data point).
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FIGURE 10 Different concentrations of 3-AAB which allow 
10% of wild-type and various mutant cells lines 
to survive (see also table 9 (A)).
1 0  T
5
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lines in order to obtain the same effect as that found for w ild-type cells. In wild- 
type cells, the cytotoxicity of 3-AAB increased dramatically at concentrations 
above those giving 70% survival, whereas in m utant cell lines it was achieved at 
concentrations above those giving 30% survival. However, as seen on survival 
curves [figure 9 (a-d)]. the increase in cytotoxicity of 3-AAB on m utant cell lines 
was more gradual compared to the survival curve of w ild-type cells.
Results obtained so far indicate that m utant cell lines are defective in certain 
functions related to the inhibitory effect of 3-AAB which normally affects w ild- 
type cells.
4.2.3 Cell membrane permeability to 3-AAB
The transport of 3-AAB across the cell membrane has been investigated to ascertain 
whether mutation is affecting cell membrane permeability. M utant cells grown in 
suspension medium of RPMI 1640 (no inhibitor) were collected (during mid- log 
phase, at 2.0-2.5xl05 cells/m l) by aspirating cells to give a final cell density of 
5 x l0 6 cells/ml. A total volume of 3 ml was incubated w ith 15 jul of [3H]3-AAB. 
A t various time intervals of 5 min, 30 min. 1. 2 and 3 h; lxlO6 cells (200 jul) were 
filtered through a W hatman GFC disc and washed with 3x10 ml of ice cold PBS.
For the background control, untreated cells (1x10** cells) filtered through a GFC disc were washed 
with an equal volume (200jil) of radioactive medium followed by the washing procedure of PBS. 
The counts obtained provided the background of radioactive counts which were not inside the 
cells.
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The discs were dried at room temperature and the radioactivity determined (see 
method chapter 3.7). The results are presented in table 10 and figure 11 and they 
show that 3-AAB diffused into the cells to reach equilibrium very quickly as the 
radioactive count (cpm) at 5 min and 3 h are very similar. Results show that the 
amount of 3-AAB accumulated in various m utant cell lines is greater compared to 
w ild-type cells (as shown by the radioactive count per 106 cells): it is increased by 
a factor in the range of 2.0-2.8. This increased factor is probably due to the sizes of 
m utant cells which are larger (see figure 8) than the wild-type, hence m utant cells 
accumulate more 3- AAB inside themselves. This experiment demonstrates that 
mutation in m utant cells was not due to their cell membrane permeability as 3- 
AAB passes through the membranes.
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TABLE 10 Radioactive count of [ 3H] 3-acetamidobenzamide, presented 
as c.p.m. x 103 per 106 cells in wild-type and various 
m utant cell lines. Each data point consists of an 
average of 3 determinations (see also figure 11).
Cell lines Incubation Times
5 min 30 min l h 2 h 3 h Mean value I.F.
W ild-type 1.1±.07 1.2±.06 1.1 ±.03 1.1 ±.06 1.0±.09 1.1±.05 1
M utant 3 2.5±.07 2.4±.09 2.6±.12 2.5±.08 2.6±.12 2.5±.08 2.3
4 2.1±.05 2.4± .ll 2.2±.12 2.1+.07 2.3±.07 2.2±.13 2.0
5 2.9±.12 2.8±.12 3.0±.15 2.9±.16 2.9±.15 2.9±.07 2.6
6 2.1±.02 2.2±.10 2.0±.16 2.0±.07 2.0±.12 2.0+.08 1.8
7 3.0±.14 2.9±.l6 3.1±.18 3.3±.10 3.2±.19 3.1±.15 2.8
9 2.7+.06 2.5±.12 2.4±.12 2.3±.06 2.6±.10 2.5±.15 2.3
10 3.0±.12 3.2± .ll 2.9±.15 3.2±.05 3.0±.12 3.0±.13 2.7
12 2.6+.15 2.6±.17 2.5±.12 2.7± .ll 2.6±.09 2.6±.07 2.4
13 2.6±.12 2.6±.17 2.5±.15 2.4±.15 2.5+.18 2.5+.08 2.3
14 2.6±.09 2.5+.06 2.6±.16 2.8±.08 2.5±.09 2.6±.08 2.4
15 3.0±.17 2.8±.12 2.9±.15 2.9±.15 3.2±.20 3.0±.15 2.7
16 2.8±.15 3.0±.13 3.1±.17 2.9±.15 3.2±.15 3.0±.16 2.7
I.F. = the ratio of uptake of [3H] 3-AAB in w ild-type to each m utant cell line.
W ild-type and m utant cell lines (5x l06 cells/ml; total volume 3ml ) were 
incubated with 15 jul of [3H] 3-AAB (117 nCi/ml). A t various time intervals, 
lxlO 6 cells were filtered through a glass fibre disc and washed w ith 3x10 ml PBS.
The radioactivity of [3H] 3-AAB inside the cells was determined according to the 






























FIGURE 11 Radioactivity count of [3H] 3-AAB transported 
inside wild-type and mutant cell at various 
incubation periods (see also table 10).
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CHAPTER 5
THE CHARACTERIZATION OF ADP-RIBOSYLATTON IN VARIOUS MUTANT
CELL LINES
CHAPTER 5
M utant cell lines were tested in the following sections to determine whether or not 
they contain the enzyme ADPR transferase and whether their NAD biosynthesis is 
maintained at the normal levels using [14C] nicotinamide as a precursor. M utant cell 
lines were also tested for their responses to DNA damaging agents in the presence 
and absence of 3- acetamidobenzamide(3-AAB), as ADP-ribosylation is known to be 
involved in DNA repair (chapter 1.1.9). The results obtained would provide the 
preliminary evidence if their survival in high concentration of 3-AAB (a 
concentration toxic to wild- type cells) is related to ADP-ribosylation. 
Furthermore, the cytotoxicity of 3-aminobenzamide and 3-nitrobenzamide (also 
ADPR transferase inhibitors) together with their acid analogues were tested on all 
m utant cell lines to determine if they are also resistant to high concentrations of 
these compounds.
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5.1 AN INVESTIGATION OF ADPR TRANSFERASE ACTIVITY IN 
PERMEABILIZED MUTANT AND WILD-TYPE CELL LINES
ADPR transferase is a nuclear enzyme which catalyses the synthesis of poly (ADP- 
ribose) (chapter 1.1.3). The enzyme cleaves NAD to yield free nicotinamide and 
ADP-ribose moiety. It also transfers ADP-ribose to various acceptor proteins such as 
histones, RNA polymerase or even to ADPR transferase itself (chapter 1.1.4).
The substrate for ADPR transferase is NAD, a macromolecule which can not be 
supplied directly to the interior of intact cells. Most investigations of poly (ADP- 
ribose) synthesis in mammalian cell lines have therefore been conducted by 
permeable cell techniques, in which cells could be rendered permeable to 
exogenously supplied nucleotide. The method of cell permeabilization used for this 
investigation is based on the method of Durkacz et al (1980 a), which has been 
adopted from the original development of Berger et al (1978). They have 
demonstrated that studies in the permeable cells provide a more physiological 
assessment of the poly (ADP-ribose) synthesis than could be obtained by studies 
w ith isolated nuclei.
For the experimental system in this section, w ild-type and mutant cell lines were 
prepared (see chapter 3.4.4) and used during log growth phase; 5-7xl05cells/ml for 
w ild-type cells and 2-2.5xl05cells/ml for m utant cells (as the maximum cell 
density during early stionary phase is 106cells/ml for wild- type and 3.5-5 
x l0 5cells/ml for various m utant cell lines). Cells were pelleted in a bench 
centrifuge and resuspended in hypotonic buffer (as described in chapter 3.10) at 4 
deg.C. Aliquots of m utant cells were taken at various times and mixed with an
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equal volume of trypan blue and observed under the microscope. Microscopic view 
of a population of permeabilized m utant cells showed a mixture of both permeable 
and non- permeabilized cells such that only 30% of m utant cells were permeabilized 
after 15 min incubation period. A maximum of 75% of the cells were permeabilized 
after 45-50 min. leaving the other 25% unpermeabilized even if the incubation 
period was extended. The suspension of m utant cells in hypotonic buffer was, 
therefore, left on ice for 45-50 min before being diluted 10 fold with isotonic buffer 
(see chapter 3.10) ready for the assay.
However, 95-100% of wild-type cells were permeabilized within 15-20 min. but as 
the enzyme activity in m utant cell lines was to be compared with the wild-type, 
all cell lines were therefore treated under the same experimental conditions (ie 
w ild-type cells were incubated w ith hypotonic buffer for 50 min). The ADPR 
transferase activity of wild-type cells (measured as initial rate of reaction) 
determined after 15 min was shown to be within the maximum upper limit of 
standard deviation of enzyme activity determined after 50 min incubation, (see 
figure 13a). For each experiment, 5 ;ul of [3H] NAD in 50% ethanol (v /v ) (23 
mCi/jumole) was added to 245 til of cells in buffer solution (0.5xl06cells). The 
experiment was carried out at 26 deg.C and a 25 ^ul sample was taken at various 
time points up to 5 min. The ADPR transferase was determined by measuring the 
incorporation of [3H] NAD into acid-insoluble material as described in chapter 3 
(sections 7 and 8)
When ADPR transferase was assayed in the presence of ImM 3- 
acetamidobenzamide, the inhibitor was added 5 min prior to the ADPR transferase 
assay.
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RESULTS
The ADPR transferase activity in wild-type and mutant cell lines was
measured for 5 min. Figure 12 (a-d) shows a typical time course of poly (ADP- 
ribose) synthesis in various cell lines measured as the incorporation of radioactive 
ADP-ribose from  [3H] NAD into TCA products in the presence and absence of ImM 
3- acetamidobenzamide. A time course of poly (ADP-ribose) synthesis obtained for 
w ild-type cells showed an initial rapid uptake for the first 1.5-2 min which was 
linear followed by a much slower rate of synthesis (non-linear) up to the 
incubation time of 5 min (figure 12a). A similar time-course was also observed in 
m utants 6, 9, 13 and 16 (figure 12b), although a small decrease in poly (ADP- 
ribose) synthesis in these cells after 3-5 min was observed. This small decrease (or 
decay) was not so significant compared to the rapid decreases obtained in other 
m utant cell lines shown in figure 12 (c&d).
A time-course of poly (ADP-ribose) synthesis in m utants 7 and 14 (figure 12c) 
showed a rapid rate of uptake in the first 1 min period followed by a decrease in the 
rate of uptake between 2-3 min for m utant 7, and for mutant 14 this remained 
level for 1 min. This was prior to a gradual decrease in the rate of polymer 
synthesis of 0.08±0.01 and 0.05±0.02 pmole/min/106cells respectively.
Poly (ADP-ribose) synthesis obtained for m utants 3. 4, 5, 10, 12, and 15 also 
showed rapid initial rates of reaction for the first 1-2 min (as obtained in wild-type 
cells). Instead of continuing to maintain their incorporation rates of poly (ADP- 
ribose) synthesis in the non-linear fa^ion during the plateau as observed in wild- 
type cells, however, the poly (ADP-ribose) synthesis showed a rapid decrease which 
was linear (figure 12 d)
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Figure 12 (a-d) clearly showed that ADPR transferase activity in all m utant cell 
lines was completely inhibited by 1 mM 3-acetamidobenzamide.
The initial rate of poly (ADP-ribose) synthesis (pmole/min/106 cells) and the 
maximum amount of polymer synthesis of wild- type and m utant cell lines 
together w ith the rate of decay (pmole/m in/106cells) observed in some m utant cell 
lines are summarized in table 11 and presented as graphs in figures 13 (a, b and c 
respectively).
The m ajority of mutant cell lines exhibited similar initial reaction rates of poly 
(ADP-ribose) synthesis to w ild- type (figure 13 a) which were within the range of 
(0.41 - 0.67) p mole/min/106cells. The initial reaction rates of poly (ADP-ribose) 
synthesis in m utants 3 and 4 however were shown to be 50% lower compared to 
w ild-type cells. The initial reaction rates of incorporation of w ild-type cells, 
m utants 3 and 4 were 0.59, 0.25 and 0.31 pmole/min/106cells respectively.
Figure 13 (b) shows the maximum amount of poly (ADP-ribose) synthesized 
(plateau) in wild-type and m utant cell lines. The maximum amount of polymers 
obtained during plateau period in most m utant cell lines (except mutants 3 and 4) 
were w ithin the same range of standard deviation of w ild-type cells. There was a 
marked difference in the maximum amount of poly (ADP-ribose) synthesized in 
w ild-type cells and m utants 3, 4 and 10. For m utants 3 and 4 it was in the order of 
3 fold lower and in m utant 10, 2 fold lower.
After the plateau, the amount of NAD incorporated in some m utant cell lines 
decreased. This was observed as the rate of decay of poly (ADP-ribose) which was 
observed in m utants 3, 4 , 5. 7, 10, 12, 14 and 15 (m utants shown on figure 12 c,d).
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TABLE 11 The sum m ary of poly (ADP-ribose) synthesis in wild-type 
and m utant cell lines measured as the incorporation of 
[3H] ADPR from [3H] NAD in permeabilized cells 
(as described and presented in figure 12).
A B C
Cell line pm ole/m in/ pmole/ pmole/min/ N
number 106 cells 106 cells 106 cells ey
W ild-type .59±.18 1.03+.24 NONE 7
M utant 3 .25±.05 .33+.09 .06+.02 8
4 .31+.03 .37±.10 .07±.01 3
5 .51±.12 .80±.13 .09±.03 4
6 .54±.15 .86±.17 N.S. 3
7 .55+. 11 .80±.19 .08±.01 6
9 .62±.18 .72±.23 N.S. 3
10 .41±.06 .47±.10 .08±.03 3
12 .50±.08 .73±.15 .06±.03 3
13 .53±.19 .65±.21 N.S. 4
14 .65±.19 .78±.18 .05±.02 3
15 .67±.20 .80±.16 .09±.01 3
16 .52±.18 .86±.21 N.S. 4
N.S. = not significant
(A) The initial rate of poly (ADP-ribose) synthesis for w ild- type and m utant cell 
lines ( [3H] ADPR incorporated , pmole/min/106 cells). (See also figure 13 a).
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TABLE 11 (continue)
(B) The maximum amount of poly (ADP-ribose) synthesized during the plateau 
period (maximum [3H] ADP-ribose incorporated (pmole/106 cells). (See also figure
13 b).
(C) The rate of decay of poly (ADP-ribose) after the plateau period 
(decay of [3H] ADP-ribose (pm ole/m in/106 cells). (See also figure 13 c).
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FIGURE 12.a Time course of poly (ADP-ribose) synthesis in 
wild-type cells measured as the incorporation 
of pH] ADPR from pH] NAD in permeabilized 
cells in the presence (+AAB) and absence (-AAB) 
of ImM 3-AAB.(Graph shows a  t y p i c a l  tim e 



















0 1 2 3 4 5 6
Time (min)
Cells (0.5x106) were incubated with 5 ul pH] NAD in a total volume of 250 pi. At 
various time intervals, 25 jiil was spotted on to Whatman filter paper disc 
(presoaked in 20% (w /v) TCA). The discs were washed and radioactivity 


























FIGURE 12.b Time course of Poly (ADP-ribose) synthesis in
mutants 6,9,13.16 cells measured as the
incorporation of pH] ADPR from pH] NAD in
permeabilized cells in the presence (+AAB) and
absence (-AAB) of 1 mM 3-AAB, as described in figure 12 -a.










m utant 16m utant 13
1 0 -
(+ AAB)
 r-— i------ 1------ 1------ 1------1  1------ 1------1------ 1-------1------ 1
0 1  2 3 4 5 6  0 1  2 3 4  5 6
Time (min)
- 103 -
FIGURE 12.c Time course of poly (ADP-ribose) synthesis in 
m utants 7,14cells measured as the incorporation 
of [3H] ADPR from pH] NAD in permeabilized 
cells in the presence (+AAB) and absence (-AAB) 
of 1 mM 3-AAB, as described in figure 12-a.
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FIGURE 12.d Time course of Poly (ADP-ribose) synthesis in 
mutants 3,4.10,5,12,15 cells measured as the 
incorporation of pH] ADPR from pH] NAD in 
permeabilized cells in the presence (+AAB) and 
absence (-AAB) of 1 mM 3-AAB.as described in figure 12.a.
(Graphs show a ty p ic a l  tim e course o f  se v e r a l exp erim en ts).
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FIGURE 13.a Initial rate of polv (ADP-ribose) synthesis
(pm ole/m in/106 cells) of wild-type and various 
m utant cell lines, measured as the 
incorporation of pH] ADPR from pH] NAD in 
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FIGURE 13.b The maximum amount of poly (ADP-ribose)
systhesized by w ild-type and various m utant cell 
lines during the plateau period (pmole/106 
cells) measured as the incorporation of [3H]
ADPR from [3H] NAD in permeabilized cells as 
presented in table 11 (B).
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FIGURE 13.c The rate of decay of poly (ADP-ribose) after 
the plateau period in w ild-type and various 
m utant cell lines (pm ole/m in/106 cells) 
measured as the degradation of poly (3H~ADP- 
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The rate of decaying was within the range of (0.05-0.09) pmole/min per 106cells 
(see figure 13 c).
DISCUSSION
The results show that all m utant cell lines possess ADPR transferase activity. The 
incorporation of radioactivity from [3H] NAD into TCA insoluble products 
represents the net rate of ADP-ribosylation (ADPR transferase activity less, poly 
(ADP- ribose) glycohydrolase and ADP-ribosyl protein lyase activities). The net 
rate of ADP-ribosylation of most m utant cell lines during the initial rates of 
reaction (except m utants 3 and 4 ) may be occuring by a similar process to that of 
wild-type cells. Moreover, most m utant cell lines (except 3, 4 and 10) produce a 
similar amount of polymer products during the plateau period to w ild-type cells 
(figure 13, b). Both results indicate that the mechanism of ADP-ribosylation in 
w ild-type and m utant cell lines are similar. It is not clear whether the ADPR 
transferase enzyme is identical in all cell lines or if the amount of enzyme is the 
same. As no significant differences were observed in the initial rates of reaction and 
in the maximum amount of polymers produced in all mutant cell lines (except 
m utants 3. 4, 10) it is assumed that the enzyme in most mutant cells remain 
unchanged.
The ADPR transferase of m utants 3 and 4 may possess more initiation sites than
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ADPR transferase of wild-type cells. Multiple initiation sites were first reported by 
Ueda et al. (1980) and was supported by Kristen et al. (1985) and Bauer et al. (1986) 
who showed that mono ADP-ribose adducts were synthesized when isolated rat 
liver nuclei were incubated with low levels of NAD (nanomolar concentration). If 
ADPR transferase in m utants 3 and 4 contains multiple initiation sites, the major 
products shown on table 11 (over 80%) are probably mono ADP-ribose-enzyme 
protein initiators (Bauer et al., 1986) which are very unstable (Yoshihara et al., 
1977; Ueda et al., 1980) making measurement of the product difficult.
That ADPR transferase in m utants 3 and 4 may possess multiple initiation sites is 
concluded from the increasing initial rates of reaction of ADPR transferase when 
permeabilized cells of m utant 3 were incubated with increasing concentrations of 
NAD (table 12, figure 15). It is interesting that the lower activity of ADPR 
transferase in m utant 3 compared to wild-type cells is only observed when a low 
level of NAD concentration was used (ie 0.86 jliM). This concentration was used in 
all mutant cell lines (figure 12 a-d). ADPR transferase activity of m utant 3 is 
apparently higher than w ild-type cells when the NAD concentration used was 4.26 
juM or greater (see table 12). This could be explained by the many initiator adducts 
(mono- ADP-ribose-enzyme protein) being further elongated to form polymers in 
higher concentrations of NAD, as it has an unlimited supply of substrate.
The lowering of the initial rates of poly (ADP-ribose) synthesis observed in 
m utants 3 and 4 may reflect the increase in apparent Km of the enzyme for NAD. 
The apparent Km of ADPR transferase for NAD of m utant 3 and w ild-type cells 
together with their Vmax were estimated by the method of Line weaver and Burk 
(1934) and it is shown in figure 14 and table 13. The kinetic parameters of the 
reaction indicates tha t the apparent Km for NAD of wild-type cells is 32 ;uM and
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the Vmax is approximately 16 pmole/min/ 106 cells. In contrast, the apparent Km 
for NAD of m utant 3 is 3 times higher (106 jiM) and the Vmax, also 3 fold higher, 
is equal to 52 pmol/min/106 cells. This kinetic behavior of the polymer further 
suggests tha t the enzyme in m utant 3 is preferentially catalyzing the initiation 
[mono-(ADP-ribosyl) ation] of protein rather than the elongation [poly-(ADP- 
ribosyl) ation] of proteins when a lower level of NAD was used (ie 0.85 ^uM). 
Hence low ADPR transferase activity is observed in m utant 3 as compared with 
w ild-type cells (table 11).
The difference in NAD affinity of ADPR transferase in m utant 3 and wild-type cell 
lines may also be due to the different level of enzyme-associated DNA defined as 
sDNA which is DNA attached to ADPR transferase. It was found that the Km for 
NAD of ADPR transferase purified from calf thym us varies from 40 juM to 216 jiM 
which corresponds to the amount of sDNA present which was 10.5 to 1.5 ng 
respectively (Neidergangef al., 1979). The exact catalytic mechanism which makes 
DNA necessary for poly (ADP-ribose) synthesis is not known but there are 
indications that one of its roles may be in ADP- ribose chain elongation (Bauer and 
Kun, 1985).
Another reason for the differences in the ADPR transferase activity of m utants 3 
and 4 as compared to w ild-type cells may be due to multiple forms of enzyme as 
proposed by Dungan et al. (1974). These authors suggest that ADPR transferase 
exists in multiple forms based on the differences in properties of crude soluble and 
particulate enzyme preparations. It has also been suggested that there might be 
more than one ADPR transferase present inside the cells as two Km values were 
observed in HeLa cells. Km values of 42 juM NAD in S phase nuclei and 75 juM 
NAD in G2 phase nuclei were found for poly (ADP-ribose) synthesis (Kidwell and
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TABLE 12 Summary of poly (ADP-ribose) synthesis in wild-type 
and m utant 3 measured as the incorporation of 
[3H] ADPR from [3H] NAD in permeabilized cells at 
various concentrations of NAD, as described and 
presented in figure 16 a & b (results obtained 
from 3 independent experiments).
NAD wild-type cells Mutant 3 cells
(A) (A) IB)
(jiM) pmole/min/ pmole/min/ pmole/m
106 cells 106 cells 106 cells
4.26 1.40+0.08 2.0+0.32 0.13+. 02
14.54 5.20+0.78 6.0+2.10 0.27+.09
35.06 8.24+1.70 12.5+1.50 0.34+.08
69.26 11.02+2.00 20.2+6.25 N.S.
137.66 13.75+2.10 28.0+1.12 N.S.
N.S. = Not significant
(A) The initial rate of poly (ADP-ribose) synthesis (pmole/min/106 cells)
(B) The rate of decay of poly(ADP-ribose) after the plateau period 
(pm ole/m in/106 cells)
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TABLE 13 Apparent Km for NAD of ADPR transferase and Vmax of poly 
(ADP-ribose) synthesis in wild-type and m utant 3 cell lines 
determined by the method of Lineweaver and Burk as shown 
on figure 14 (results obtained from 3 determinations).
Km Vmax
;uM pm ole/m in/106cells
W ild-type 31.23 ± 2 .05  16.23 ± 3.4
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FIGURE 15 Initial rates of poly (ADP-ribose) synthesis
(pmole/m in/106 cells) of wild-type and m utant 3 
cells at various concentrations of NAD measured 
as the incorporation of [3H] ADPR from [3H] NAD 
in permeabilized cells. See also table 12.
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Burdette, 1974). The above factors may contribute to the differences in the ADPR 
transferase activity observed in m utants 3 and 4.
The ratio of acceptor protein to DNA is also found to influence ADPR transferase 
such that the peak of ADPR transferase activity occurs at HI : DNA ratio of 
between 1.0 and 2.0 and the enzyme was most active when the ratio was between 1.5 
and 2.0. The ADPR transferase activity dropped rapidly at ratios outside this range 
(Carter and Berger, 1981a). |
Evidence that DNA content in the mammalian cell lines influences ADPR 
transferase activity has been reported by Chatterjee and co-workers (1987). They 
found that one of their variant cell lines [11(81)1], which has the lowest enzyme 
activity compared to its w ild-type and other variant cell lines, also has the highest 
DNA content per cell. The DNA content per 106 cells in variant 11(81)1, is also 2 
fold higher than its w ild-type. Moreover, ADPR transferase activity in variant 
11(81)1 cells was 37% of the ADPR transferase measured in the w ild-type cells. 
Such a result is similar to m utant 3 and w ild-type cells (as shown on table 11) 
where ADPR transferase activity of m utant 3 is approximately 40% of the ADPR 
transferase activity in w ild- type cells (see also figure 13 a).
The difference in the maximum amount of poly (ADP-ribose) synthesized observed 
in m utants 3, 4 and 10 as compared to wild-type cells (figure 13 b) may be due to 
the different levels of various acceptor proteins present in the cells. It was reported
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TABLE 14 DNA content in mutant 3 and wild-type cells.
Cell lines ;ng DNA per 106 cells
W ild-type 15.83 ± 1.3
M utant 3 29.66 ±1.5
The ratio of DNA content in wild-type cells to m utant 3 = 1.0 : 1.9
The DNA content of m utant 3 and wild-type cells was measured according to 
Burton assay which is described in methods (chapter 3.12). Data shown above were 
obtained from 3 independent experiments each performed in quadruplicate.
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tha t the acceptor protein of ADP-ribosylation is dependent on NAD content. At 
higher concentrations of (>10 juM) NAD, histone HI is the major acceptor protein of 
ADP-ribose in pancreatic nucleosomes (Aubin, 1982a, b) and at lower concentrations 
(< 1  ;uM) the major acceptors are core histones and such accessibility of core 
histones to ADPR transferase was found to be dependant on the automodification 
state of the enzyme (Huletsky et al., 1985).
The apparent decline or decay in poly (ADP-ribose) synthesis after the plateau in 
mutants, shown on figure 13 c, was probably complicated by an increase in the 
degradation of the polymer which could be produced by an increase in NAD 
glycohydrolase activity resulting in excessive substrate (NAD) consumption 
(Nakazawa et al., 1968) or by poly (ADP-ribose) glycohydrolase or
phosphodiesterase resulting in rapid decrease in poly (ADP-ribose). Poly (ADP- 
ribose) glycohydrolase cleaves the ribose-ribose bond between adjacent ADP-ribose 
units yielding an ADP-ribose monomer (Miwa and Sugimura, 1971).
Phosphodiesterase hydrolyzes the phosphodiester bonds of poly (ADP-ribose) 
producing AMP, phosphoribosyl AMP and ribose 5’-phosphate (Shinshi et al., 1976) 
hence an increase in activity in either of these two enzymes in m utant cells could 
cause rapid degradation of poly (ADP-ribose). The half-life of poly (ADP-ribose) 
was found to be quite short. A half-life of 1 min was reported by Hilz's group 
(Wielckens et al., 1982). The sudden loss of poly (ADP- ribose) after 1-2 min in 
some of the m utant cell lines (m utants 3, 4, 5, 7, 10, 12, 14, 15 see figure 13 c) 
indicates that it is the result of an excess of degradation over synthesis caused by 
degrading enzymes, possibly by poly (ADP- ribose) glycohydrolase as
phosphodiesterase is not considered to play a major role in vivo due to its lower 
specificity and affinity to the polymer (Miwa and Sugimura, 1982).
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A detailed kinetic study of m utant 3 (as shown on table 12 and figure 16 a) shows 
tha t at higher doses of NAD, the product is still decreasing after 1-2 min of 
reactions. The rate of decay is 0.13, 0.27 and 0.34 pmole/min/106 cells for 4.26, 
14.54 and 35.06 pM NAD respectively. The decrease in the rate of polymer 
synthesis has given further weight to the suggestion that poly (ADP-ribose) 
glycohydrolase in m utant 3 is in such excess that the time course does not slow the 
decay. However, at much higher doses of NAD (69 pM NAD) the rate of product 
decay in m utant 3 is very small and at 137 ;uM NAD, the product remains almost 
constant after 3 min reaction. This demonstrates that the constant net balance of 
synthesis and breakdown is probably due to the excess supply of NAD. In wild- 
type cells, at concentrations above 14 pM NAD (figure 16 b) the increase in polymer 
synthesis is observed for 5 min followed by a plateau, which remains for up to 20 
min. This demonstrates that the net balance of synthesis and breakdown is 
achieved in w ild-type cells at a much lower concentration of NAD (ie at 14 juM for 
w ild-type and at 69 juM for m utant 3).
It can be concluded that all m utant cell lines possess ADPR transferase and that 
most m utant cell lines have a similar enzyme activity to wild-type cells. The lower 
ADPR transferase activity observed in m utants 3 and 4 are probably due to the 
various reasons previously described. Furthermore, the Km for NAD and the Vmax 
value in m utant 3 are shown to be higher than those obtained for wild-type cells. 
This kinetic parameter indicates that ADPR transferase in m utant 3 is different 
from ADPR transferase in w ild-type cells. There is evidence that most m utant cell 
lines possess larger amounts of degrading enzymes as shown by the rate of decay of 
poly (ADP- ribose) after the plateau as shown in figure 13 c.
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FIGURE 16.a Time courses of poly (ADP-ribose) synthesis of m utant 3 cells measured 
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Cells (0.5xl06) were incubated with various NAD concentrations of 4.26, 14.54, 
35.06, 69.26 and 137.66 uM with radioactivity specificity activity of 5.4, 1.6, 0.67, 
0.33 and 0.17 mCi//amole NAD respectively. Total volume of 250 jul w'as carried 
out at 26 deg.c. At various time intervals, an aliquot of 25 jul was spotted on 
Whatman filter paper disc (presoaked in 20% (w /v ) TCA). Discs were washed and 


























FIGURE 16.b Times courses of poly (ADP-ribose) synthesis in 
wild-type cells measured as the incorporation 
of [3H] ADPR from [3H] NAD in permeabilized 
cells in various concentrations of NAD as 
described in figure I6.a.
6 t
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5.2 NAD BIOSYNTHESIS IN MUTANT AND WILD-TYPE CELL LINES USING 
[14C] NICOTINAMIDE AS PRECURSOR.
The conversion of nicotinamide to NAD has been reported to occur in various ways. 
It can enter the nicotinic acid pathway after deamination (Prevss and Handler. 1958) 
or it can be converted to NAD via nicotinamide mononucleotide as an intermediate 
(Dietrich et al., 1966). It was shown that under the conditions normally used for 
culture, the net biosynthesis of NAD proceeds from nicotinamide by a single 
pathw ay with nicotinamide mononucleotide as the only intermediate (Jacobson et 
al., 1979a). This pathway was demonstrated in L1210 cells in this laboratory. It 
was shown that nicotinamide is taken up by L1210 cells and incorporated into 
nicotinamide nucleotide of which 90% is converted into NAD (Al -Muhtaseb, 1985). 
This finding is in general agreement w ith those of Hillyard et al. (1973) using BHK 
21/13 fibroblasts, murine 1921 and human D98/AH2 and Jacobson and 
Narasimham (1979) using mouse 3T3 cells. Some mammalian cells can also 
synthesize NAD from nicotinic acid and trytophan (Hillyard et al., 1973). 
However, these NAD precursors are prim arily utilized by the liver, which converts 
them to nicotinamide and releases the product into the systemic circulation 
(Bernofsky, 1980).
ADPR transferase is the main NAD degrading enzyme, exclusively located in the 
nucleus (chapter 1.1.3). In this process of poly (ADP-ribose) synthesis, 
nicotinamide is regenerated and converted back to NAD via the sequential action of 
NMN pyrophosphorylase and NAD pyrophosphorylase in a series of reactions that 
consumes 5 - phosphoribosyl-1-pyrophosphate (PRPP) and ATP (see figure 1).
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In this experiment, NAD biosynthesis in various m utant cell lines was determined 
using [14C] nicotinamide as a direct precursor. This investigation was carried out to 
ascertain whether NAD is synthesized normally via nicotinamide, in various 
m utant cell lines. If mutation occurs at one of the enzymes responsible for this 
process results obtained should indicate this possibility when they were compared 
with wild- type cells.
It was shown earlier in this laboratory tha t w ild-type L1210 cells labelled with 
low levels of [14C] nicotinamide reached equilibrium labelling at 10 h of incubation 
and remains in equilibrium for up to 72 h and then decreases (see figure 17). 
Various m utant and wild-type cell lines were therefore labelled with [14C] 
nicotinamide for a period of 48 h as this should ensure that all cell lines have 
reached their maximum uptake.
Various m utant and w ild-type cell lines were prepared as described in methods 
(chapter 3.4.4). A culture bottle of cells was grown in normal RPMI, at cell density 
of 5-7xl04 cells/ml, in the presence of [14C] nicotinamide (0.5 ;uCi in 50 ml culture) 
and left undisturbed in the C 02 incubator.
A fter 48 h, the extracellular [14C] nicotinamide was removed. First the medium was 
carefully aspirated into a small volume (about 10 ml) leaving cells undisturbed and 
then the cells were collected by centrifugation (1000 rpm for 5 min^A^he 
supernatant removed. The pellet was resuspended in cold 15 ml PBS and then 
centrifuged as before. This washing procedure was carried out a number of times 
and the radioactivity of the supernatants was counted. It was shown that the 
extracellular radiolabel is reduced to background levels after 4 washings (see table 
15). Therefore, all cell lines labelled w ith [14C] nicotinamide were always washed
- 123 -
FIGURE 17 [14C] Nicotinamide incorporation into wild-type
h
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The uptake of labelled [14C] nicotinamide in wild-type L I210 cells. These were 
grown in RPMI medium containing [14C] nicotinamide. At the time shown, the cells 
were washed 4 times(4*15ml RPMI) and radioactivity counted as described in 
chapter 3.7.
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4 times w ith 15 ml PBS. Cells were collected by microcentrifuge (high speed for 1 
min) and ethanol was added to give a final solution of 50% (v /v). Finally, the 
suspension (about 200 p i) was sonicated at 15 w for 15 sec with an ultrasonicator 
using a probe of diameter 4.5 mm. This procedure was repeated 3 times after 1 min 
intervals. The mixture was recentrifuged (high speed/1 min) and the supernatant 
was assayed for NAD content. The method of thin layer chromatography (t.l.c.) in 
butanol system was used to separate radioactive NAD and nicotinamide (see chapter 
3.8). This system is so sensitive that it will separate nicotinamide and nicotinic acid 
from pyridine nucleotides (NAD. NADH. NADP). Rf values for nicotinamide and 
nicotinic acid are 0.71 and 0.31 respectively, whereas pyridine nucleotides remain at 
the origin. Radioactivity from various spots on t.l.c. plates (see figure 18) were 
expressed as percentage fraction of total radioactivity of each plate. Results are 
summarized and presented in table 16.
RESULTS
The t.l.c. plates of various m utant cell lines were developed and the radioactivity 
determined. It was shown that there were only 2 spots which exhibited 
radioactivity (see figure 18). One was at the origin (spot A) which could be 
identified as a pyridine nucleotide (NAD, NADH and NADP) as it has Rf value of 0 
and the other was nicotinamide (spot B) as it has Rf value of 0.71. The majority of 
radioactivity (>  85%) of total radioactive counts for various m utant and wild-type 
cell lines was found to be at the origin w ith the remaining of 10- 15% near to the 
top of t.l.c. plates. There was no trace of nicotinic acid on all plates developed.
Table 16 summarized the percentage fraction of [14C] nicotinamide on t.l.c. plates, 
identified as NAD, NADH and NADP (Rf =0) and nicotinamide (Rf =0.71). Results
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TABLE 15 Washing procedure to remove extracellular radiolabeled 
from m utant and wild-type cell lines.






Cells were labelled with [14C] nicotinamide for 48 h and harvested by 
centrifugation (1000 rpm for 5 min). The supernatant was removed and the cells 
washed. A sample (200 jul) was taken from each supernatant and radioactivity 
was counted.
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show tha t 90% of nicotinamide in w ild-type cells was incorporated into pyridine 
nucleotides. Similar results were also observed for various m utant cell lines. In 
some m utant cell lines (m utants 9, 12, 14, 15 and 16) only 86% of nicotinamide 
was incorporated into pyridine nucleotides, but this small difference was considered 
to be insignificant.
DISCUSSION
The level of various nicotinamide metabolite (using [14C] nicotinamide as precursor)
"h
in w ild-type cells was determined by Al-Mu'taseb (1985), using Dowex Ion- 
Exchange Chromatography. This method can separate nicotinamide plus NMN, NAD 
and NADH. Results obtained showed that the ratios of nicotinamide/NMN to NAD 
and to NADH is 3-5% : 86-90% : 3-5%. Furthermore, this ratio remains constant 
during the growth cycle of w ild-type cells.
NAD biosynthesis of w ild-type and various m utant cell lines are carried out in the
h
same experimental procedure as Al- Mutaseb (1985). Moreover, results obtained 
for various m utant cell lines are similar to w ild-type cells. This indicates that 90% 
of [14C] nicotinamide is incorporated normally into nicotinamide nucleotides and 
tha t the majority of the product is likely to represent NAD as found in w ild-type 
cells.
Although the pathways of NAD biosynthesis are not determined, the route of this
process in m utant cells can be safely assumed to proceed from Nm->NMN-*NAD as
shown in the t.l.c. plates run in the butanol system (see figure 18); and as shown by
other workers using 3T3 cells (Jacobson et al., 1979 a) and w ild- type L1210 cells 
h
(Al-Mutaseb, 1985). During the analysis of nicotinamide nucleotides, there is no
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TABLE 16 Estimation of [14C] nicotinamide incorporated into NAD
and nicotinamide nucleotides in various m utant and wild-type 
cell lines using thin layer chromatography (butanol system), 
(results obtained from 3 determinations).
Cell lines % radiolable on % radiolable on
spot A spot B
NAD/NADH/NADP Nicotinamide
(Rf =0) (Rf =0.71)
W ild-type 90.0 ± 0.8 10.0 ± 1.0
M utant 3 89.0 ± 1.6 11.0 ± 1.7
4 90.0 ± 0 .8 10.0 ± 1 .0
5 89.0 ± 1.5 10.6 ± 2.0
6 91.6 ± 1.2 8.3 ±2 .0
7 91.0 ±0.8 9.0 ± 1.0
9 86.5 ± 0.5 13.5 ± 0 .5
10 91.1 ±0.8 9.0 ± 0.6
12 87.7 + 1.4 13.0 ± 1.0
13 90.3 ± 1.5 9.7 ±2.5
14 86.6 ± 0.9 13.4 ± 1.3
15 86.0 ± 1.5 14.0 ± 1.2
16 88.0 ±2 .0 12.0 ±1.5
Cells were labelled with [14C] Nicotinamide for 48 h ( 0.5 juCi in 50 ml of culture 
medium), then washed 4 times to remove extracellular radiolabel. Finally, 50% 
(v /v ) ethanol was added to cells, followed by sonication (3x15 sec). A sample of 
supernatant was analysed by t.l.c. using the butanol system and the radioactivity
on t.l.c. plates was determined. Results expressed as percentage fraction of [14C] 

















FIGURE 18 R adioactivity profile produced by
chromatography of labelled mutant and wild-type 
cell lines in the butanol system (as described 
in table 16).
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evidence of the degradation of nicotinamide to nicotinic acid in all the cell lines
tested. This also indicates that there is no active nicotinamide deaminase. The t.l.c.
plates also show no evidence of nicotinamide conversion of N’ - methylnicotinamide
(Lee et al., 1971). The t.l.c. butanol system would have detected nicotinic acid and
any metabolites even as low as 0.01% of the total labelled pool. The possibility that
any nicotinic acid formed might have been directed into NaMn-»NaAD-» NAD in
such a fast step that it could not be detected by t.l.c./butanol system was proved
h
not to be the case in wild- type cells by Al-Muvtaseb (1985). The analysis of 
radiolabelled nicotinic acid uptake had shown that it was not further metabolised to 
NaMn or NaAD.
The possibility that the [14C] label of nicotinamide or nicotinamide nucleotides leaks
out of the m utant cells during washing was considered to be very unlikely. All the
nicotinamide in the form of nucleotides would not be able to pass through an intact
cell membrane because of it being phosphorylated. If nicotinamide nucleotides were
to leak out. only a tiny percentage of the total label inside the cell would probably
diffuse out of the cells in its attem pt to reach equilibrium w ith the extracellular
enviroment. In cultured cell lines, nicotinamide generated during NAD catabolism
is re-utilized preferentially for NAD synthesis and it was found that it did not
equilibrate rapidly with extracellular nicotinamide pools (Hillyard et al., 1981). It
was also found that [14C] label of nicotinamide and nicotinamide nucleotides leaks
out of wild-type cells quite slowly and that after a period of 4 h, only 10% of the
h
total [ C] label inside the cells had diffused into isotope-free medium (Al-Mutaseb, 
1985).
Cell membrane permeability of m utant and w ild-type cell lines to 3- 
acetamidobenzamide is shown to function normally (chapter 4.2.3). Based on this
- 130-
observation, it is assumed that the cell membrane permeability of m utant cell lines 
to nicotinamide and nicotinamide nucleotides would function in a similar manner to 
w ild-type cells. Even if [14C] label in m utant cell lines could leak out at a faster 
rate than w ild-type cells due to a larger surface area, this is very unlikely to affect 
the results since the washing period is very short (30-40 min). The amount of [14C] 
label that leaked out should, therefore, be very small.
It can be concluded that NAD is synthesized normally in m utant cell lines in the 
route of Nm-^NMN-^NAD as normally found in most culture cell lines.
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5.3 THE ENHANCEMENT OF CYTOTOXICITY OF DMS BY 3- 
ACETAMIDOBENZAMIDE ON MUTANT AND WILD-TYPE CELL LINES
It has been demonstrated that treatm ent of cells w ith DNA damaging agents results 
in a rapid lowering of NAD levels with a concomitant increase in ADPR transferase 
activities (Whish et al., 1975; Skidmore et al., 1979; Durkacz et al., 1980a). The 
increase in ADPR transferase activity may be brought about by either alkylating 
agents, irradiation or endonucleases. The common effect of all these agents is that 
they ultim ately result in increased ADPR transferase levels in a dose dependent 
manner as observed by Durkacz et al. (1980a). suggesting that ADP-ribosylation 
may have a role in DNA repair. This hypothesis is supported by the finding that 
addition of inhibitors of ADPR transferase such as 3- aminobenzamide and 5- 
methylnicotinamide markedly increase the cytotoxicity of DNA damaging agents by 
preventing the rejoining of strand break and the resuming of replicative DNA 
synthesis (Durkacz et al., 1980a; D urrant and Boyle. 1982). The above phenomena 
together w ith further work carried out by Shall’s group have led to the inference 
that ADP-ribosylation regulates DNA repair, possibly in the ligation step (Creissen 
and Shall. 1982). It was reported earlier that nutritional depletion of the cellular 
content of NAD has been found to greatly reduce the rate of DNA rejoining in L1210 
cells after treatment w ith DMS (Jacobson et al., 1979b).
The enhancement of cell killing by ADPR transferase inhibitors on cells treated 
w ith DNA damaging agents is due to inhibition of nuclear ADPR transferase with a 
consequent inhibition of DNA repair. M utant cell lines were therefore treated with 
DMS in the presence and absence of a non-toxic concentration of 0.5 mM 3- 
acetamidobenzamide (3-AAB). If one of the enzymes involved in DNA repair is
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genetically altered, the cells surviving in m utant cell lines should have different 
capacities to survive compared to w ild-type cells.
In this investigation, DMS was used as a DNA damaging agent. It is an electrophilic 
compound (Miller, 1970) which reacts w ith nucleophilic sites in DNA, particularly 
the N? of guanine and to a lesser extent, the N? of adenine (Lawley, 1966). The 
introduction of the methyl group at N7 of guanine labilizes the glycosidic linkage 
between the N9 of purine and Cj of the deoxyribose, thus making the bond more 
susceptible to hydrolysis. Although the N7 of guanine is not involved in hydrogen 
bonding, the methylation of DNA at this position leads to the production of 
apurinic sites which is followed by the production of single strand breaks in the 
polynucleotide backbone. Thus damage to DNA will result in helix distortion and 
the loss of function in biological processes such as replication, transcription and cell 
growth. Cells however possess the capacity to cope with limited damage to their 
DNA in the form of repair process, such that the damaged regions are enzymatically 
removed from DNA and replaced by a new sequence of intact nucleotide with the 
gap being closed by ligase action (Lehmann and Bridges,1977).
The survival assay in soft agar (see chapter 3.4.5) is used to determine the 
cytotoxicity of DMS and the enhancement effect (if any) of 3-AAB on various 
m utant cell lines. The cytotoxicity of DMS on wild-type cells resulted in cell death 
(50%) when treated with 50 pM  DMS and a greater percentage of cell death ( > 95%) 
was observed when 3-AAB (at non-toxic concentration) was introduced to cells 
prior to DMS treatm ent (Sujareerat, 1985). The experiments were therefore carried 
out at 50 juM DMS as its cytotoxicity permits a greater observation of cell killing in 
the presence and absence of 3- AAB.
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The main object of this investigation is to determine whether 3-AAB, at a non-toxic 
concentration, would enhance the cytotoxicity of DMS in various m utant cell lines. 
It was also considered that a single dose of DMS treatment (at 50 pM) and DMS 
w ith 3-AAB (0.5 mM) on each m utant cell line would be sufficient to give 
preliminary evidence on cell survival. If a cytotoxicity dose response curve of both 
treatments, with various concentrations of DMS, were to be investigated on all 
m utant cell lines, this would have taken a long time to achieve bearing in mind the 
number of cell lines tested and the length of time required for the colonies to form.
M utant and wild-type cells were prepared (see chapter 3.4.4) and used during their 
log growth phase. Cell cultures were always divided into 2 bottles (5 ml each). 
One was treated w ith DMS only and other w ith DMS and 3-AAB. This procedure 
was taken to ensure that both treatment groups started at the same cell density so 
tha t the results obtained could be compared more accurately within the same cell 
line. For the combined treatment, 3-AAB was always added to cell cultures 10 min 
prior to DMS treatment and this was to ensure that 3-AAB was present during 
immediate repair after DNA damage. 3-AAB was also present in the soft agar 
during the colonies forming period, so its cytotoxic effect could be observed on the 
entire process of DNA repair. The process of DMS treatm ent and cell plating in soft 
agar was described in methods (chapter 3.4.5).
After 2-3 weeks, the colonies from each of the treatm ent groups of various m utant 
cell lines were counted and presented in table 17. The precentage increase in cell 
killing of DMS by 3-AAB is calculated using the equation below.
(Colonies in DMS treatment - Colonies in DMS + 3-AAB) x 100 
Colonies in DMS treatm ent
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RESULTS
Results in table 17 showed that DMS was toxic to all m utant cells. Very few cells 
(out of 100 cells plated) were capable of repairing damage to its DNA and resume a 
normal division to form colonies. Less than 10 colonies were observed for most 
m utant cell lines treated with DMS alone. Some m utant cell lines (eg m utants 9, 10, 
13. 14, 15 and 16) show a greater number of cell survival in which 20-40 colonies 
were observed. A greater number of colonies (50-80 colonies) were observed in 
w ild-type cells.
Cell survival in DMS and 3-AAB treatment in all m utant cell lines were clearly 
shown to be lower than DMS treatm ent alone. Very few cells (less than 10 cells for 
m utant cell lines and 40 for w ild-type cells out of 1000 cells plated) were capable 
of repairing their DNA damage in the presence of 3-AAB (ADPR transferase 
inhibitor) and therefore able to form colonies.
DISCUSSION
It is clearly demonstrated that 3-AAB enhanced the cytotoxicity of DMS in all 
m utant cell lines. The enhancement factor, presented as the percentage increase in 
cell killing of DMS by 3-AAB, shows that more than 90% of cells surviving in DMS 
treatm ent are killed when 3-AAB is present throughout the entire DNA repair 
process. This finding is similar to that of w ild-type cells which demonstrates that 
3-AAB was equally effective at potentiating the killing of m utant cells when 
treated w ith DMS. Results obtained from this experiments lend no support to the 
possibility that ADP-ribosylation is impaired or altered in the process of DNA
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TABLE 17 Cell survival of m utant and w ild-type cell lines following 
treatm ent with 50 ;uM DMS in the presence and absence of 
0.5 mM 3-acetamidobenzamide (3-AAB) as described in 
methods (chapter 3.4.5) The values given are the mean 
of colonies ± standard deviation of 5 determinations.
Cell lines Expt No A B C
W ild-type 1 57 0 ±6 .2 15.0 ±3.8 97
L1210 cells 2 81 2 ± 4.9 39.0 ±5 .8 95
3 50 0 ± 5.6 10.0 ± 3.6 98
M utant 3 1 12 0 ± 0.8 5.3 ± 0.5 96
2 14 8 ± 3.5 5.0 ± 2.2 97
3 3 3 ± 1.5 0.8 ± 0.5 98
M utant 4 1 6 3 ± 0.9 6.8 ± 0 .9 90
2 2 0 ± 0.8 1.8 ± 0.9 92
3 2 5 ± 0.6 1.0 ±0 .8 96
M utant 5 1 2 0 ± 0.8 2.8 ±0.5 87
2 2 3 ± 0 .7 1.0 ±0 .8 93
3 1 5 ± 0 .6 2.8 ± 0.5 90
M utant 6 1 2 0 + 1 .2 2.5 ± 1.7 96
2 7 5 ± 1.0 5.3 ± 0 .5 95










1 5 0 ±0 .8  2 .0 ± 0 .8  96
2 7 0 ± 0.8 3.3 ± 0 .7  95
3 2 5  ±1 .3  2.0 ±1 .4  92
1 8 0 ± 2.7 0.8 ±0 .5  99
2 22 8 ±7 .4  5.0 ±0 .8  98
3 32 3 + 5.1 11.8 + 1.0 96
30 0 ±1 .6  7.8 ± 0 .9  94
11 3 ± 3 .3  7.0 ±2 .5  90
21 0 + 2.6 5.3 + 1.0 97
15 0 ±1 .5  1.5 ± 1 .0  99
9 0 ± 2.6 3.8 ± 0 .5  96
8 8 ± 2 .0  7.3 ± 1 .0  92
1 42 0 ± 4 .5  18.0 ±2 .5  96
2 22 3 ± 5 .0  . 17.3 ± 5 .0  93
3 17 5 + 2.0 5.8 ±0 .9  97
1 37 0 ± 5 .2  30.2 ± 1 .7  92
2 44 5 ± 8 .8  46.0 ± 5 .5  90
3 22 0 ± 2 .4  11.5 ± 3 .9  95
1 4 5 ±2.1 1.3 ± 0 .9  93
2 18 0 + 2.2 3.3 + 1.5 98
- 137 -
TABLE 17 (coniinue)
Mutant 16 1 13 8 ±4.0  4.5 ± 2.0 97
2 34 0 ±8.1 15.0 ± 4 .6  96
10*
(A) Colonies obtained fromA100 cells plated following 5 0 ;uM DMS treatment
(B) Colonies obtained from 1000 cells plated following 50 ;uM DMS + 0.5 mM 3- 
AAB
(C) The percentage increase in cell killing of DMS by 3-AAB. Calculated from 
equation below:
(Colonies in DMS only - colonies in DMS+3-AAB) x 100 
Colonies obtained in DMS only
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repair in mutant cell lines.
The results obtained also agree with other published work (Durkacz et al., 1980 a; 
Nduka et al., 1980; Jacobson et al., 1984). which demonstrated that processes 
sensitive to inhibition by nicotinamide analogues are required for cellular recovery 
from DNA damage. The studies of the cytotoxicity effects of monofunctional 
alkylating agents were carried out in variuos cell types, such as L1210 cells and 
human fibroblasts (Cleaver et al., 1983; Durrant and Bolye, 1982; James and 
Lehmann. 1982) and various ADPR transferase inhibitors, for example 3- 
aminobenzamide and 5- methylnicotinamide. The degree of enhancement of 
cytotoxicity by such inhibitors is highly variable, depending upon cell types and 
DNA damaging agents.
As described in the introduction (chapter 1.1.5), the cytotoxicity effects of ADPR 
transferase inhibitors on various cell lines, reported by various workers, are not 
only due to their action on ADPR transferase. Some reports suggest that the 
inhibitors interfere w ith other metabolic pathways for example purine metabolism 
(Cleaver et al., 1983) and the de novo synthesis of DNA purines (Cleaver et al., 
1983; Milan and Cleaver, 1984). Moreover, the enhancement effect of 3-AAB may 
be due to the effect on folate metabolism as 3-AAB was found to inhibit the 
incorporation of [14C] formate (in w ild-type cells treated with MNNG) into ATP 
and GTP. It may also have inhibited glycine incorporation into ATP and GTP and 
reduced both the incorporation of thymidine into DNA and the specific activity of 
the d TTP pool as suggested by Hunting et al. (1985)
3-AAB may affect m utant cells in the same functions as described above. Reports 
from various sources have also suggested that ADPR transferase is activated by
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DNA damaging agents and is consequently inhibited by ADPR transferase 
inhibitors. Furthermore, the toxic synergism demonstrated in the reports is due to 
an inhibition of ADPR transferase (see chapter 1.1.9)
The increased cell killing observed in these m utant cell lines could be due to the 
influence on the cellular machinery that controls repair as observed in w ild-type 
cells. Such investigations of the mechanism have proved difficult due to the great 
complexity of chromatin and of the subdivision of the cell cycle, especially the S 
phase. For the surviving colonies, DNA strand breaks caused by DMS are 
ultim ately repaired. The delayed repair and persistence of breaks associated w ith 
the requirement of ADP-ribosylation is likely to have resulted in the increased 
frequency of genomic rearrangement as suggested by Lunec et al. (1984). They 
reported that more genomic rearrangement had taken place in murine lymphoma 
cells when ADPR transferase activity was inhibited by 3-AAB.
The cell survival of m utant cells following DMS and 3-AAB treatm ent also depends 
on the state of the individual cells during growth cycle. As cells are used during 
their log growth phase, the majority of cells are therefore in the state of dividing 
cells. 3-AAB is probably acting at the S phase of the cell cycle, resulting in cell 
cycle inhibition. This suggestion is based on the results of Jacobson et al. (1984) 
who found that an inhibitor of ADPR transferase (3- methoxybenzamide) delayed 
inhibition of DNA synthesis in MNNG treated exponentially dividing cells but not 
in the non-dividing cells (Jacobson et al.,1985 b). Various studies also suggest that 
dividing cells following DNA damage require an increased rate of ADP-ribosylation 
in order to complete the S phase and progress through the G2 and M phase. When 
ADPR transferase inhibitors were presented, they prevented cells from recovering, 
especially from G2 which eventually leads to cell death (Das et al., 1984; Boorstein
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and Pardee, 1984).
The cloning in soft agar, used for observing the enhancement effect of DNA 
damaging agents, has a limited use as only the end point (forming colonies) is 
adopted in determining the effect of inhibitor on cell recovery from DNA damage. 
Moreover, the cells capable of only 1 to 3 doublings are not counted as survivors, 
whereas measuring the overall rates of cell division in suspension medium includes 
this increase. The study of cells in soft agar therefore precludes many biochemical 
analyses, particularly at early times following DNA damage. This technique 
however is extremely sensitive because only individual cells capable of repetitive 
division proliferate to produce a visible colony.
Results from this experiment have indicated that the cell survival 
following DMS treatm ent in m utant cell lines and wild-type cells are similar. 3- 
AAB is shown to enhance the cytotoxicity of DMS with the same degree of 
enhancement in m utant and w ild-type cell lines.
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5.4 THE CYTOTOXICITY OF 3-AMINOBENZAMIDE (3-AB), 3-
NITROBENZAMIDE (3-NB), 3-AMINOBEZOIC ACID (3-ABA), 3- NITROBE?ZOIC 
ACID (3-NBA) AND 3-ACETAMINOBENZOIC ACID (3- AABA) ON MUTANT 
AND WILD-TYPE CELL LINES
Results obtained so far have shown that the genetic alterations in m utant cell lines 
were not due to:
1) The cell membrane being impermeable to 3-AAB (chapter 4.2.3)
2) A defect in the ADP-ribosylation process. (ADPR transferase (see 5.1) and 
NAD synthesis (see 5.2) is shown to be present). Furthermore, the cell survival of 
m utant and wild-type cell lines following DMS treatment in the presence and 
absence of 3-AAB are shown to be similar. It was subsequently decided to see if 
these m utant cell lines (which are resistant to a toxic concentration of 3-AAB) were 
also resistant to the toxic concentrations of other ADPR transferase inhibitors. As 
results from various experiments have indicated that the mutation is not related to 
ADP- ribosylation. this implies that the mutation may be specific for the function 
related to the cytotoxicity of 3-AAB. This can be determined if m utant cell lines 
are not shown to be resistant to 3-AB and 3-NB.
3-Aminobenzamide (3-AB) and 3-nitrobenzamide (3-NB) are ADPR transferase 
inhibitors w ith Ki values of 2.6 and 9.6 juM respectively (Purnell and Whish, 
1980). The acid analogues 3- aminobenzoic acid (3-ABA) 3-nitrobenzoic acid (3- 
NBA) and 3- acetaminobenzoic acid (3-AABA) which are not ADPR transferase 
inhibitors (Purnell and Whish, 1980) were also tested on m utant cell lines. The
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major structural differences between 3-AAB, 3-AB and 3-NB are the acetyl, amino 
and nitro groups on the 3 substituted benzamide (see figure 4.b). The lack of the 
amide nitrogen and the ionization of the acid groups in the acid analogues together 
with their both being planar and very polar are the major differences between the 
parental amide and their acid analogues.
The cytotoxicity of 3-AB, 3-NB, 3-ABA, 3-NBA and 3-AABA was tested on w ild- 
type cells. It was shown earlier that high concentrations of 3-AB and its acid 
analogue 3-ABA and 3-AABA are required in order to have any cytotoxic effect on 
wild- type cells. A much lower concentrations of 3-NB and its acid analogue (3- 
NBA) are required for a similar effect (Sujareerat, 1985). W ild-type cells (at 
5x l0 4cells/ml) were treated with various concentrations of 3-AB, 3-ABA, 3-NB, 3- 
NBA and 3-AABA in the suspension medium (as shown in table 18). A t various 
time intervals, normally every 24 h up to 96 h, cell density was counted. The 
doubling times of cells in various treatments were determined and presented in 
table 18.
Results showed that the concentrations of 14, 24, 3. 4 and 15 mM for 3-AB, 3-ABA, 
3-NB, 3-NBA and 3-AABA, respectively, had a cytotoxicity effect on w ild-type 
cells. Their cytotoxicity effects increased the normal doubling time of cells from 
12 h to about 40 h. Moreover, the maximum cell density of lOOxlO4 cells/ml 
observed at the stationary phase (in the absence of inhibitors) was reduced to about 
20xl04cells/ml. It was therefore decided to test the cytotoxicity of the above 
concentrations of various compounds on m utant cell lines. If m utant cell lines are 
to be resistant to 3-AB and 3-NB, the concentrations of both compounds used 
(which are toxic to w ild-type cells) should not have any effect on m utant cell lines. 
The cytotoxicity of the acid analogues on m utant cell lines should also provide more
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TABLE 18 Comparison of growth rates and the maximum cell 
density of w ild-type cells in the presence of 
various concentrations of 3-aminobenzamide (3-AB), 
3-aminobenzoic acid (3-ABA), 3-nitrobenzamide (3- 












RPMI - 12.8 ± 1.5 100 ± 12.0
3-AB 10 25.0 ±5 .2 70 ±  8.0
12 30.0 ± 4.2 55 ± 7.5
14 42.6 ± 8.8 22 i  5.3
3-ABA 20 20.0 ± 2.5 80 ± 7.8
22 30.2 ± 5.0 50 ± 3.0
24 41.5 ±3 .2 21 ± 4.5
3-NB 2 27.0 ± 3 .0 52 ± 7.5
3 43.3 ± 7.2 15 ± 3.6
3-NBA 2 18.0 + 2.0 80 + 10.0
- 144 -
TABLE 18 (continue)
3 23.4 ± 1.2 60 ± 3.2
4 40.0 ± 8 .0  28 ± 3 .5
3-AABA 10 18.0 ± 2 .0  90 ±  10.0
15 52.6 ± 8 .3  14 ± 3.9
W ild-type cells at 5x l04 cells/ml were treated with various concentrations of the 
above compounds and at various time intervals (of every 24 h up to 96 h), cell 
density was determined. Cell cycle doublng times were determined from the slopes 
of the growth curves (6 determinations). Slopes were calculated from least square 
regression analysis of data.
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evidence that the cytotoxic effects observed are not on ADPR transferase.
Various m utant cell lines were prepared (chapter 3.4.4) and subcultured during log 
growth phase into the media contaning 14, 24, 3, 4 and 15 mM of 3-AB, 3-ABA, 3- 
NB, 3-NBA and 3-AABA respectively. Cells were always started at 5x l0 4cells/ml 
in a culture bottle of 5 ml. Cell density was monitored at various time intervals, 
norm ally at every 24 h up to 96 h or longer. The maximum cell density at the 
stationary phase was also observed. The doubling times of m utant cell lines in 
various treatments were determined and presented in table 19. The ratios of 
doubling times of each cell line in the presence of inhibitors and acid analogues to 
its doubling time (within the same cell line) in the absence of various compounds 
are shown in table 20. These ratios are also presented as graphs in figure 19 (a-d). 
The summary of maximum cell density of all cell lines are presented in table 21 
and as graphs in figure 20 (a, b, c).
RESULTS
Since the concentrations of various compounds were toxic to w ild-type cells, the 
results obtained for m utant cell lines should provide sufficient evidence for the 
preliminary investigation. Results showed that the compounds tested were toxic to 
all m utant cell lines. The effects of their cytotoxicity on m utant cell lines vary 
from completely inhibiting cells from the process of cell division (no proliferation) 
to lengthening their doubling times. The cytotoxicity of 24 mM 3-aminobenzoic 
acid completely inhibited cell proliferation in m utants 6, 7, 9, 10 and 16. This 
observation was also observed in m utants 6, 9, 10, 12, 13, 14 and 16 for 3 mM 3- 
nitrobenzamide treatment, in m utants 6, 13 and 16 for 4 mM 3-nitrobenzoic acid 
treatm ent and in m utants 6, 7, 10, 12, 15 and 16 for 15 mM 3-acetamidobenzoic
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acid treatment. For mutant cells that achieved the process of cell proliferation, 
however, at least 40 h or longer was required for cell population to double (see 
table 19)
Table 20 shows the increased time required for each cell line receiving various 
treatments to achieve their doubling cell density (cells/ml) (ie compared to its 
doubling time in the absence of treatment). ADPR transferase inhibitors and their 
acid analogues were toxic to wild-type cells such that cells require at least 3 times 
longer than their normal doubling time (no treatm ent) in order to achieve the 
doubling cell density. Most m utant cell lines also required at least 2 or 3 times 
longer in the presence of various compounds in order to achieve the doubling cell 
density. M utant 3 was shown to be the least sensitive to the cytotoxicity of 
inhibitors and acid analogues. The factor (time) by which cells increased their 
doubling cell density in various treatments was only 1.5-2.0 times longer than its 
normal doubling time. An increase factor of time, less than 2, was also observed in 
mutant 4 for 3-nitrobenzoic acid, m utant 10 for 3-aminobenzamide treatment and 
in m utant 12 for 3- aminobenzamide and 3-nitrobenzoic acid treatment (see also 
figure 19 a, b, c and d).
Table 21 shows the maximum cell density of m utant cell lines in various 
treatments at the stationary phase. Results showed that the maximum cell density 
in most m utant cell lines was less than 50% of the maximum cell density obtained 
in normal media RPMI (see also figure 20 a, b, c). The maximum cell density of 
mutant 3 following 3-aminobenzamide and 3 acid analogues treatment was shownto 
be 50% or over of the maximum cell density in normal media RPMI. This 
observation is also observed in m utant 4 following 3-acetamidobenzoic acid (3- 
AABA) and 3- nitrobenzoic acid (3-NBA) treatm ent and in m utant 5 for 3-AABA
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TABLE 19 Summary of the doubling times of m utant and wild-type cell lines in the 
presence of 14 mM 3-aminobenzamide (3-AB). 24 mM 3-aminobenzoic acid 
(3-ABA), 3mM 3- nitrobenzamide (3-NB), 4 mM 3-nitrobenzoic acid (3- 
NBA) and in 15 mM 3-acetamidobenzoic acid (3-AABA). (See figure 19 a, b, c. d).
Cell lines Non-
Treatment
3-AB 3-ABA 3-NB 3-NBA 3-AAB
W ild-type 12+2 42+8 41+ 3 43+ 7 40+8 53+8
Mutant 3 29+1 42± 8 51+9 58+9 43+3 51+9
4 23+1 51+4 54+5 90+12 44+ 7 50+8
5 24+2 64+11 45+9 70+5 68+10 60+12
6 29+3 84+12 N.P. N.P. N.P. N.P.
7 20+1 51+11 N.P. 85+ 7 79+12 N.P.
9 23+1 *59+7 N.P. N.P. 70+10 91+13
10 24+2 43+6 N.P. N.P. 79+12 N.P.
12 26+2 50+4 53+ 4 N.P. 41+6 N.P.
13 20+1 60+9 57+8 N.P. N.P. 69+12
14 24+2 70+10 80+11 N.P. 69+12 74+9
15 20+2 44+5 44+ 3 69+4 76+12 N.P.
16 22+2 44+ 7 N.P. N.P. N.P. N.P.
N.P. = Non-Proliferative
Vaxious cell lines at an initial cell density of 5 x l0 4cells/ml were grown in the 
presence of the above compounds and cell density was counted every 24 h (to a 
maximum of 96 h). Cell cycle doubling times of various treatments were
determined from the slopes of the growth curves (6 determinations). Slopes were 
9
calculted from least square regression analysis of data.
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TABLE 20 Ratios of doubling time of each cell line (wild- 
type and m utant) in the presence of various 
compounds (dt+) to its doubling time in the 
absence of compounds (d t-) (as described in table 
19;) presented as:-
(dt+ )/(d t-). See also figure 19 (a, b, c, d).
Cell lines dt(+AB) dt(+ABA) dt(+NB) dt(+NBA) dt(+A
dt(-) d t(-) d t(-) d t(-) d t(-)
W ild-type 3.5 3.4 3.6 3.3 4.4
Mutant 3 1.5 1.8 2.0 1.5 1.7
4 2.3 2.4 3.9 1.9 2.2
5 2.7 1.9 2.9 2.9 2.5
6 2.9 0 0 0 0
7 2.6 0 4.3 4.0 0
9 2.6 0 0 3.0 4.0
10 1.8 0 0 3.3 0
12 1.9 2.0 0 1.6 0
13 3.0 2.9 0 0 3.5
14 2.9 3.3 0 2.9 3.0
15 2.2 2.2 3.5 3.8 0
16 2.0 0 0 0 0
d t = doubling time
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TABLE 21 Maximum cell density at the stationary phase of m utant and w ild-type 
cell lines in various treatments with 14 mM 3-aminobenzamide (3-AB), 24 mM 3- 
aminobenzoic acid (3-ABA), 3 mM 3-nitrobenzamide (3-NB), 4 mM 3-nitrobenzoic 
acid (3-NBA) and 15 mM 3-acetamidobenzoic acid (3-AABA).
Cell lines Non­
treatm ent
3-AB 3-ABA 3-NB 3-NBA 3-AA
W ild-type 100±12 22±5 22±4 15±3 28±4 14±2
M utant 3 41± 7 27±4 21+4 11+4 25±3 21+3
4 38+ 6 16+3 13±2 10+2 26+5 20+3
5 37± 3 16±2 15+3 10+3 14±2 19+6
6 32+ 6 10+3 N.P. N.P. N.P. N.P.
7 46+ 5 18+5 N.P. 10±2 10±2 N.P.
9 37± 3 15+4 N.P. N.P. 14±2 11+3
10 40+ 5 14±3 N.P. N.P. 12+3 N.P.
12 41+ 5 12+2 10+3 N.P. 18+4 N.P.
13 38± 5 13±3 12±3 N.P. N.P. 10+2
14 34+ 3 15+4 10+2 N.P. 10+2 15+2
15 33+4 14±2 10+3 11±3 11+2 N.P.
16 35+ 3 16+3 N.P. N.P. N.P. N.P.
N.P. = Non-proliferative
4
Cellsat an initial cell density 5x10 cells/ml, were grown in suspension media RPMI 
containing various compounds as above and cell proliferation was monitored from 0 
h up to about 96 h so that the maximum cell density could be counted (6 
determinations). See also figure 20 (a-c).
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FIGURE 19.a Doubling limes of m utants 3,4,5 and w ild-type cell lines in the presence
of 14 mM 3-aminobenzamide (3-AB). 24 mM 3-aminobenzoic acid 
(3-ABA), 3 mM 3-nitrobenzamide (3-NB), 4 mM 3- nitrobenzoic acid 
(3-NBA) and in 15 mM 3- acetamidobenzoic acid (3-AABA) as described 









































FIGURE 19.b Doubling tim es of m utants 6 ,7 ,9  and 10 in the



































FIGURE 19.c Doubling tim es of m utants 12,13,14 and 15 in
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FIGURE 19.d Doubling tim es o f mutant 16 in the presence of




































FIGURE 20.a Maximum cell density (cells/ml) at the
stationary phase of wild-type and m utants 3,4.5 
cell lines in the presence of 14 mM 3-AB. 24 mM 
3-ABA, 3 mM 3-NB. 4 mM 3-NBA and 15 mM 3-AABA 
as described in table 21. For the control, 
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FIGURE 20.b Maximum cell density (cells/ml) at the
stationary phase of mutants 6,7,9,10,12 and 13 
cell lines in the presence of various compounds 
as described in figure 20.a.
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FIGURE 20.c Maximum cell density (cells/m l) at the
stationary phase of m utants 14,15 and 16 cell 
lines in the presence ol various compounds as 
described in figure 20.a.
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This method of measuring "cell survival" in liquid culture has an advantage over 
estimation of "cell survival" assay of cloning in soft agar as the former method is 
simpler and more convinient to perform, results can be obtained within 3-4 days. 
The latter method is a more stringent test as it directly estimates the ability of the 
individual cells to repair damagedDNA or overcome the inhibitory effects of ADPR 
transferase inhibitors and resume normal division to form colonies but the process 
is slow and it requires at least 2-3 weeks to obtain the results.
This method of measuring the cytotoxicity of various compounds on m utant cell 
lines has shown that the cell cycles of m utant cell lines are affected by the ADPR 
transferase inhibitors and the acid analogues which resulted in the treated cells 
requiring longer times to undergo the process of cell division. M utant 3 is the least 
sensitive whilst m utants 6 and 16 are the most sensitive towards 3-nitrobenzamide 
and all the acid analogues. M utant cell lines that are sensitive to acid analogues 
(m utants 6, 7, 9, 10, 12, 13, 15 and 16) indicates that their target is not ADPR 
transferase but that they may interefere with other metabolic processes.
Results obtained for this investigation show that m utant cell lines are sensitive to 
14 mM 3-aminobenzamide and 3 mM 3- nitrobenzamide (these concentrations are 
toxic to wild-type cells). Although m utant 3 is less sensitive to 14 mM 3- 
aminobenzamide and the 3 acid analogues, it is sensitive to 3mM 3-nitrobenzamide. 
This may be due to the combined effects of the nitro and the amide groups. The 
carboxylate ion of 3- nitrobenzoic acid at physiological pH may not contribute to
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the cytotoxicity which resulted in the differences in the sensitivity of 3- 
nitrobenzamide and its acid analogue.
M utant and wild-type cell lines were treated with high doses of compounds for 
long periods of time. The effect of cytotoxicity of ADPR transferase inhibitors on 
m utant and wild-type cell lines can not be solely based on the assumption that it 
results from the inhibition of poly (ADP-ribose) synthesis. This is due to recent 
reports emerging in the last few years which suggest that ADPR transferase 
inhibitors also affect other metabolic pathways. Cleaver et alX 1983) reported that 
3-aminobenzamide (3-AB) inhibits the de novo pathway of purine biosynthesis as 
shown by the reduction of[14C] label in adenine and guanine in HeLa cells. The 
same group (Milam and Cleaver, 1984) has further reported that 3-AB significantly 
inhibited the incorporation of [3H] methionine and [14C] glucose into DNA and that 
3-aminobenzoic acid affects the salvage routes of DAN synthesis by reducing the 
[3H] thymidine incorporation into DNA and glucose metabolism as measured by the 
rate of conversion of D-[14C]-glucose to^C02- The inhibition incorporation of [3H] 
m ethyl group of methionine into deoxyguanosine, deoxyadenosine and 
particularly deoxycytidine by 3-AB was found to occur even at concentrations as 
low as 1 mM. Results also suggest that 3-AB affects the metabolism of 1 carbon 
pool which is essential for de novo purine and pyrimidine biosynthesis, especially on 
the pathway for de novo pyrimidine deoxynucleotide synthesis as it reduced the 
incorporation of radioactively labelled [3H] glucose into pyrimidine to a greater 
extent than into purines. (Milam et al., (1986). Similar results were also observed 
in human fibroblasts by Poirier et al. (1985). Schwartz et al. (1983) found that the 
rate of DNA synthesis in CHO cells is inhibited in the prolonged exposure of 3- 
aminobenzamide. Boyle (1985) suggests that 3-AB behaves as a general cell poison 
by inhibiting the incorporation of [14C] formate into DNA, RNA and protein. 3-AB
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was also reported to inhibit adenosine transport (Purnell et al., 1985)
3-Nitrobenzamide is markedly more toxic to m utant cell lines compared to 3- 
aminobenzamide. Nitro-compounds have been shown to be cytotoxic and genotoxic 
which was reported to occur by the reduction to reactive intermediates which can 
then modify DNA (Biaglow 1981). It also affects molecular synthesis by inhibiting 
[3H] uridine incorporation in RNA synthesis. (Kidwell et al., 1985)
- 160-
CONCLUSIONS
The resistance of m utant cells to 3-acetamidobenzamide (3-AAB) is dramatically 
greater than that of w ild-type cells. If a defect in ADPR transferase were to be 
responsible for such resistance, it will have to be large. In the present series of 
experiments the only differences in the poly (ADP-ribose) metabolism of mutant 
and w ild-type cell lines were minor. These differences could not account for the 
observed resistance. Results have shown that there is no difference in any of the 
following aspects.
1) Poly (ADP-ribose) synthesis.
2) NAD synthesis using [14C] nicotinamide as precursor.
3) Response to DMS and its enhancement by 3-AAB.
4) The cytotoxicity of 3-aminobenzamide (3-AB) and 3- nitrobenzamide was 
equally effective on m utant and w ild- type cell lines w ith the exception that 
m utant 3 has shown a higher resistance to 3-AB.
M utant cells deficient in ADPR-transferase activity using 3-AAB as a selective agent 
in this thesis have not been found. The attempts for such m utant cells have also 
been explored in other laborateries using 5-methyl nicotinamide (Kidwell and 
Burdette, 1974; Nduka and Shall, 1980) and 3-aminobenzamide (Tavassoli et al., 
1987 b) as a selective agents. In some cases, cells were mutagenised first with 
alkylating agents and were then isolated with ADPR transferase inhibitor (M urray 
et al., 1986), or with NAD starvation (Chatterjee et al., 1987). Results obtained 
from the above investigations have shown that none of the m utant cell lines were 
deficient in ADPR transferase. Results shown in this thesis and others have
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indicated that m utation in ADPR transferase genes is probably lethal to cells such 
that a deficiency in ADPR transferase would lead to a defect in vital functions 
resulting in cell death.
Although the m utant cell lines isolated in this thesis are not the type of m utant 
which was originally sought for. they may be of value in other aspects unrelated to 
ADP-ribosylation. It is possible that the effects of 3-AAB on other metabolic 
pathways as reported by various workers (see chapter 1.1.3) other than ADPR 
transferase may no longer exist in m utant cell lines, such that the cell cycle of Gj 
and G2  in m utant cells may no longer be affected by 3-AAB as reported by Kidwell 
et al. (1985). M utant cell lines, especially m utant 3 which is shown to be resistant 
also to 3-AB. may be of use as a model cell to study the biological role of ADPR 
transferase using inhibitors as a tool such that the effect of ADPR transferase 
inhibitors (3- AAB or 3-AB) on m utant 3 may only select ADPR transferase as 
their target and not other metabolic pathways.
Further work should, therefore, be carried out on mutant 3 cells to ascertain that 3-AAB (at con­
centrations below 5 mM) does not interfere with DNA synthesis by investigation the incorpora­
tion of [3H] methionine and [14C] glucose into DNA (Milam and Cleaver 1984). The investiga­
tion of glycine incorporation into ATP and GTP and thymidine into DNA should also be carried 
out as their incorporation was shown to be inhibited by 3-AAB (at 1 mM) in L1210 and CHO 
cells (Hunting et al. 1985). If mutant 3 is shown not to be affected by 3-AAB this will provide the 
opportunity to study the biological role of ADPR transferase using 3-AAB as a tool in mutant 3 
with the certainty that it only acts on ADPR transferase and does not perturb other metabolic 
pathways. Furthermore, the determination of Ki, the rate of up-take of [3H1 3-AAB and DNA re­
pair in mutant 3 should be useful in evaluating the genetic abnormality of these mutants towards 
the resistance of 3-AAB.
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